Olympus Medical Press Releaseshttps://medical.olympuscanada.com/about/press-center/press-releases
enOlympus Canada Recognized as a Greater Toronto Top Employerhttps://medical.olympuscanada.com/articles/olympus-canada-recognized-greater-toronto-top-employer
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><!--
Olympus Canada Recognized as a Greater Toronto Top Employer
-->
<div style="float:right;width:350px;margin-left:15px;">
<img src="http://medical.olympuscanada.com/sites/default/files/ca/files/pictures/OCI-team-photo-web.jpg" alt=" " style="margin:0px;">
<p style="font-size:80%;"><em>Olympus Canada employees participate in the Big Bike event to support the Heart and Stroke Foundation of Canada.</em></p>
</div>
<p style="text-align:center;"><em>Olympus Canada Recognized as a Greater Toronto Top Employer</em></p>
<p>CENTER VALLEY, Pa., (December 7, 2018) &ndash; Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that Olympus Canada has been named one of Greater Toronto&rsquo;s Top Employers for the third year running. The award recognizes key employee benefits that support education, health, and families, including generous tuition subsidies, health spending accounts, and maternity and paternity leave for new parents.</p>
<p>&ldquo;Our business is looking after society&rsquo;s health, safety and ultimately life&rsquo;s fulfillment,&rdquo; said Bill Collins, President and CEO of Olympus Canada. &ldquo;In order to do that well, we have to look after the health and well-being of our employees, which is a responsibility we take very seriously. We are proud to receive this recognition of our efforts for a third year in a row.&rdquo;</p>
<p>Shaila Sachedina, Accounting Manager at Olympus Canada, says the Olympus mission inspires her to give more, and she sees that motivation in her team members. &ldquo;The team&rsquo;s attitude is, &lsquo;what can we do and how can we help?&rsquo; It&rsquo;s really nice to work with a group of people who care about what they&rsquo;re doing.&rdquo;</p>
<p>The Greater Toronto's Top Employers competition recognizes employers with exceptional human resources programs and forward-thinking workplace policies. Editors at Mediacorp grade employers on eight criteria: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial & Family Benefits; (4) Vacation & Time-Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. Employers are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs.</p>
<p>Olympus employee benefits considered for the award include the work-from-home option for some employees, tuition subsidies of up to $5,250 per year and subsidies for professional accreditation, two days paid leave a year for employees who want to volunteer with a nonprofit organization, and matching charitable donations of up to $2,000.</p>
<p>To learn more about Olympus Canada, please call 1-800-848-9024 or visit us at <a href="http://www.olympuscanada.com/">http://www.olympuscanada.com/</a></p>
<div style="clear:both;"></div>
<p style="text-align:center;"># # #</p>
<p><strong>About Olympus Canada</strong><br />
Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Throughout our nearly 100-year history, Olympus has focused on being true to society and making people&rsquo;s lives healthier, safer and more fulfilling.
Olympus Canada Inc. (OCI) manages the Company&rsquo;s operations and workforce throughout Canada in sales, marketing, service, and support functions. Based in Richmond Hill, ON, and recognized as one of Greater Toronto&rsquo;s Top Employers in 2017 and 2018, OCI is committed to developing our employees and supporting our local communities. Visit olympuscanada.com and <a href="http://www.truetolife.com">truetolife.com</a>.
</p>
<div style="clear:both;"></div></div></div></div>Fri, 07 Dec 2018 14:38:24 +0000Test_Publisher2792 at https://medical.olympuscanada.comOlympus Extends Portfolio for EBUS-TBNA at ATShttps://medical.olympuscanada.com/articles/olympus-extends-portfolio-ebus-tbna-ats
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><!--
Olympus Extends Portfolio for EBUS-TBNA at ATS
Olympus Extends Portfolio for EBUS-TBNA at ATS
-->
<p style="text-align:center;"><em>ViziShot 2 EBUS-TBNA Needles Provide Improved Flexibility, Increased Sharpness and an Ergonomic Handle to Help Optimize Access, Usability and Puncture of Difficult-to-Reach Lymph Node Targets</em></p>
<div style="float:right;width:350px;margin-left:15px;">
<img src="/sites/default/files/ca/files/splashPages/PR_ViziShot-Family-needles_web.jpg" alt=" " style="margin:0px;">
<p style="font-size:80%;"><em>Olympus announces new ViziShot 2 single-use aspiration needles, expanding the device portfolio for Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA), a minimally invasive alternative to a surgical procedure and considered the gold standard for lung cancer staging. The new needles will expand the line of devices from Olympus, offering improved access, usability and puncture of difficult-to-access lymph node targets.</em></p>
</div>
<p><strong>Center Valley, PA (May 18, 2017)</strong> - Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the availability of the new ViziShot 2 single use aspiration needles, expanding the device portfolio for Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA), a minimally invasive alternative to a surgical procedure and considered the gold standard for lung cancer staging. The new needles, to be unveiled at the American Thoracic Society (ATS) Annual conference, will expand the line of devices from Olympus, offering improved access, usability and puncture of difficult-to-access lymph node targets.</p>
<p>For pulmonologists performing EBUS-TBNA, the ViziShot 2 generation of needles offers enhanced precision through benefits that include:</p>
<ul>
<li>Improved access through enhanced flexibility: The advanced needle helps to support access to lymph node targets, which can be difficult to reach with conventional EBUS-TBNA needles.</li>
<li>Improved puncture via the sharper needle: The "backcut" design of the ViziShot 2 provides a sharper needle, reducing puncture force required to sample even calcified lymph nodes.</li>
<li>Enhanced usability with an ergonomic handle and redesigned colored sheath: The ergonomic handle design and improved bronchoscope adapter enable stability and precise puncture control throughout the procedure. The newly designed green-colored sheath provides excellent endoscopic visibility to ensure the needle can be deployed at the exact required location, with minimal sheath movement.</li>
<li>Two sizes: Either 21 G or 22 G is available to suit physician needs.</li>
</ul>
<p>In addition to the ViziShot 2, Olympus will demonstrate its continued commitment to pioneering in the EBUS-TBNA field by introducing the ViziShot 2 FLEX 19 G needle, that features a brand new ergonomic handle. When used with the Olympus BF-UC180F 2.2mm channel EBUS bronchoscope , it provides up to 84 degrees of angulation to help physicians gain access to the most difficult lymph node stations, such as 4L, with ease. This needle has the largest inner lumen currently available in the United States, ensuring improved sample acquisition for advanced molecular testing and enabling physicians to obtain ample quantities of the high-quality specimens needed for a comprehensive histological analysis, especially when diagnosing sarcoidosis and lymphomas.</p>
<p>"Great strides have been made in diagnosing and staging lung cancer and other diseases of the lung using minimally-invasive approaches, and we are proud of our contributions," said Kurt Heine, Group Vice President of the Endoscopy Division at Olympus America Inc. "Our continued commitment to pulmonologists to advance minimally-invasive methods is driven by the evidence that such approaches improve patient outcomes, cost containment and patient satisfaction."</p>
<p>Lung cancer is the leading cause of cancer-related deaths in the U.S., according to the Centers for Disease Control, with more than 400 Americans each day dying from the disease. Early diagnosis and accurate staging of lung cancer can lead to improved treatment. Other diseases are also better managed via EBUS-TBNA.</p>
<p>In July 2013, The U.S. Preventive Services Task Force (USPSTF) announced new recommendations for lung cancer screening for people at high risk for lung cancer, leading to increases in CT screening. Around the same time, the American College of Chest Physicians changed its lung cancer guidelines, now recommending Endobronchial Ultrasound over surgery for lung cancer staging. Many of these patients require follow-up care that could, by USPSTF estimates, prevent roughly 14% of the 160,000 lung cancer deaths each year. Recent CMS increases in reimbursement for procedures related to lung cancer diagnosis allow hospitals to more readily build their lung cancer program.</p>
<p>The new EBUS needles will be showcased at the ATS annual conference May 19-24 in Washington, D.C., booth # 923. To learn more about pulmonary therapeutic devices from Olympus, please call 1-800-387-0437 or visit us at <a href="http://medical.olympuscanada.com">http://medical.olympuscanada.com</a>.</p>
<div style="clear:both;"></div>
<p style="text-align:center;"># # #</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare. For more information visit Olympus at <a href="http://medical.olympuscanada.com">http://medical.olympuscanada.com</a>.
</p>
<div style="clear:both;"></div>
</div></div></div>Tue, 05 Sep 2017 19:43:53 +0000Test_Publisher2763 at https://medical.olympuscanada.comOlympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopyhttps://medical.olympuscanada.com/articles/olympus-endocuff-now-fda-510k-cleared-claim-improvement-adenoma-detection-rate-during
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><!--
Olympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopy
-->
<p style="text-align:center;"><em>In Screening and Surveillance, ENDOCUFF Provides Improvement in Detection of Pre-Cancerous Polyps during Colonoscopy &ndash; Reducing Risk of &ldquo;Missed&rdquo; Cancer</em></p>
<div style="float:right;width:350px;margin-left:15px;">
<img src="/sites/default/files/us/files/pictures/ENDOCUFF-Composition_FLAT.jpg" alt=" " style="margin:0px;">
<p style="font-size:80%;"><em>FDA has given 510(k) clearance for the Olympus ENDOCUFF claim that the device results in a statistically significant and clinically relevant improvement in adenoma detection rate (ADR), as compared with unassisted colonoscopy, due to its design which enables manipulation of bowel folds for maximized visualization of mucosa.</em></p>
</div>
<p><strong>CENTER VALLEY, Pa., (December 15, 2016)</strong> &ndash; Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has received FDA 510(k) clearance of claims that the ENDOCUFF &reg; endoscopic device, the previous iteration of its recently launched ENDOCUFF VISION, improves Adenoma Detection Rates (ADR) during colonoscopy over standard colonoscopy. Due to its relative newness, peer-reviewed studies are still required to show clinical equivalency of the ENDOCUFF VISION, though the material, proprietary hinge design and therefore moment of force are identical among the two products.</p>
<p>Colorectal cancer (CRC) is the second most common cause of cancer-related mortality. Colonoscopy has long been considered the gold standard for detecting colon cancer, and Olympus is the leading provider of colonoscope technology to caregivers. However, interval cancers do arise because of adenomas (pre-cancerous polyps) that are missed by the physician and can become malignant (colorectal cancer). For each 1% increase in adenoma detection rate (ADR) there is a 3% reduction in the risk of interval cancer .</p>
<p>An FDA meta-analysis has determined that the ENDOCUFF results in a statistically significant and clinically relevant improvement in ADR, as compared with unassisted colonoscopy, due to its design which enables manipulation of bowel folds for maximized visualization of mucosa. The analysis was based on several multi-center studies, one of which indicated that ENDOCUFF increases the ADR by 14.7% (95%CI 6.9-22.5%) .</p>
<p>In addition to being designed to increase ADR, the ENDOCUFF and ENDOCUFF VISION allow for controlled withdrawal of the colonoscope; are designed to minimize difficulties associated with &ldquo;looping&rdquo; of the scope; can minimize intubation force and insertion resistance; as well as minimize risk of mucosal trauma, among other claims.</p>
<p>The ENDOCUFF and ENDOCUFF VISION are devices that attach to the distal end of a colonoscope, with multiple flexible &ldquo;arms&rdquo; that fold within the product during intubation and forward movement and open out when drawn backward, thereby controlling the field of view. How the ENDOCUFF VISION works:</p>
<ul>
<li>During intubation, the flexible arms of ENDOCUFF VISION slip into the body of the device so that forward movement is not hindered.</li>
<li>The arms open and smooth the folded bowel for inspection, everting large mucosal folds and providing clear views of mucosa previously difficult to visualize.</li>
<li>During withdrawal, the flexible arms reduce the risk of sudden slippage and manipulate colonic folds, enabling a more thorough examination to be performed.</li>
</ul>
<p>&ldquo;The ENDOCUFF is the first colonoscope technology to be cleared by the FDA to claim improved adenoma detection rates,&rdquo; said Kurt Heine, Group Vice President of the Endoscopy Division at Olympus America Inc. &ldquo;Since the time that the industry has been using ADR as a standard, Olympus has been dedicated to helping its customers achieve ADR improvements &ndash; which can result in better quality of care, reduced cost, and enhanced patient satisfaction.&rdquo;</p>
<p>To learn more about the ENDOCUFF VISION, please call 1-800-848-9024 or visit us at <a href="http://medical.olympusamerica.com">http://medical.olympusamerica.com</a>.</p>
<div style="clear:both;"></div>
<p style="text-align:center;"># # #</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals to help improve clinical outcomes, reduce overall costs and enhance quality of life for patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare. For more information, visit Olympus at <a href="http://medical.olympusamerica.com">medical.olympusamerica.com</a>.
</p>
<div style="clear:both;"></div>
<hr />
<p style="font-size:80%;"><sup><a name="i">i</a></sup> Douglas A. Corley, Christopher D. Jensen, Amy R. Marks, Wei K. Zhao, Jeffrey K. Lee, Chyke A. Doubeni, Ann G. Zauber, Jolanda de Boer, Bruce H. Fireman, Joanne E. Schottinger, Virginia P. Quinn, Nirupa R. Ghai, Theodore R. Levin, and Charles P. Quesenberry, N Engl J Med 2014;370:1298-306.</p>
<p style="font-size:80%;"><sup><a name="ii">ii</a></sup> Floer M, Biecker E, Fitzlaff R, R&ouml;ming H, Ameis D, Heinecke A, Kunsch S, Ellenrieder V, Str&ouml;bel P, Schepke M, Meister T. PLoS One. 2014; 9(12):e114267</p>
<div style="clear:both;"></div>
</div></div></div>Wed, 26 Apr 2017 13:13:39 +0000Test_Publisher2755 at https://medical.olympuscanada.comOlympus Corporation of the Americas Enters into US and Canada Distribution Agreement with Arc Medical Design Ltd., a Subsidiary of Norgine for ENDOCUFF VISION®https://medical.olympuscanada.com/articles/olympus-corporation-americas-enters-us-and-canada-distribution-agreement-arc-medical-design
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><!--Olympus Corporation Of The Americas Enters Into Us And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For
Endocuff Vision &reg;
-->
<p style="text-align:center;"><em>Innovator of Device Designed to improve visualization of the Colon Joins Forces with Leader in Endoscopy</em></p>
<p><strong>CENTER VALLEY, Pa., (May 6, 2016 9:00 AM)</strong> &ndash; Olympus Corporation of the Americas today announced a new distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. by which Olympus Corporation of the Americas becomes the exclusive distributor of ENDOCUFF VISION&reg; in the U.S. and Canada. The ENDOCUFF VISION&reg; will be showcased at the adjoining Arc and Olympus booths at the Digestive Disease Week (DDW) conference in San Diego, Calif. May 22-26, 2016.</p>
<p>ENDOCUFF VISION&reg; is a 510(k) cleared, second generation, single-use device designed to improve visualization for certain endoscopic procedures such as colonoscopies. Placed on the distal tip of a colonoscope, its unique hinged arms fall flat against the shaft of the scope to reduce slippage during forward advancement. During withdrawal, the arms flare out and stabilize the tip, gently stretching the mucosal surface to allow the physician thorough inspection of the anatomy during the search for polyps.</p>
<p>"We are pleased to strengthen our commercial strategy through this relationship with Arc Medical,&rdquo; said Christos Monovoukas, VP, Business Development and Strategy at Olympus America Inc. &ldquo;This agreement represents a significant market opportunity for the Olympus endoscopy business and an important advantage for our customers and their patients."</p>
<p>Colonoscopy has long been considered the gold standard for detecting colon cancer, and Olympus is the leading provider of colonoscope technology to caregivers. Even the gold standard has room for improvement, however, in terms of interval cancers that arise because of adenomas (pre-cancerous polyps) that are missed by the physician and can become malignant (colorectal cancer). For each 1% increase in adenoma detection rate (ADR) there is a 3% reduction in the risk of interval cancer. Colorectal cancer (CRC) is the second most common cause of cancer-related mortality.</p>
<p>Tas Javed, Managing Director at Arc Medical said: &ldquo;This new distribution agreement will ensure the successful international exposure of the ENDOCUFF VISION&reg; in the U.S. and Canada. ENDOCUFF VISION&reg;, designed with input from physicians, improves tip control and visualisation during colonoscopy.&rdquo;</p>
<p>Currently ENDOCUFF VISION&reg; is sold in Europe and Australia and New Zealand through Norgine&rsquo;s infrastructure.</p>
<p>Todd Usen, President of Olympus Medical Systems Group at Olympus Corporation of the Americas, added: &ldquo;This agreement represents a combination of the best optical technology with the best new mechanical advantage to improve the physician&rsquo;s view of the anatomy that we know of. When a company leads in the field of medical technology as Olympus does for endoscopy, it is incumbent on that company to continue to raise the bar higher. It&rsquo;s this sense of responsibility that has us so excited about the potential offered by the ENDOCUFF VISION&reg;.&rdquo;</p>
<p>For U.S. product enquiries, please contact Olympus customer service at 1-800-848-9024.<br />
For Canadian product enquiries, please contact Olympus customer service at 1-800-387-0437.</p>
<p>Financial terms were not disclosed. </p>
<div style="float:left;width:336px;">
<img src="/sites/default/files/us/files/splashPages/endocuff-vision.jpg" alt=" ">
<p style="font-size:80%;"><em>Olympus announced today a new distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. by which Olympus becomes the exclusive distributor of ENDOCUFF VISION&reg; in the U.S. and Canada. ENDOCUFF VISION&reg; is a 510(k) cleared, second generation, single-use device designed to improve visualization for certain endoscopic procedures such as colonoscopies.</em></p>
</div>
<div style="clear:both;"></div>
<h2 style="text-align:center;">*ENDOCUFF VISION is Licensed by Health Canada</h2>
<p style="text-align:center;"># # #</p>
<p><strong>About Olympus Medical Systems Group </strong><br />
Olympus is a global medical device and optical technology leader focused on enhancing people's lives every day through innovative solutions in its core business areas of Medical and Surgical Products, Scientific Solutions, and Cameras and Audio Recorders. From its introduction of the first gastro-camera in 1950 to the world&rsquo;s first 5-Axis image stabilization system in mirrorless cameras, Olympus has revolutionized major advancements that are transforming the future, today.
</p>
<p>Olympus Corporation of the Americas &ndash; a wholly owned subsidiary of Olympus Corporation (OCPNY) in Tokyo, Japan &ndash; is headquartered in Center Valley, Pennsylvania and employs more than 5,000 people across North and South America. For more information, visit Olympus at <a href="http://www.olympusamerica.com" target="_blank">www.olympusamerica.com</a> and <a href="http://www.olympus-global.com" target="_blank">www.olympus-global.com</a>.</p>
<p>
<strong>About Norgine</strong><br />
Norgine is a European specialist pharmaceutical company that has been established for over 100 years. In 2015, Norgine&rsquo;s total revenue was EUR 320 million and the company employs over 1,000 people.
</p>
<p>Norgine provides expertise and &lsquo;know how&rsquo; in Europe to develop, manufacture and market products that offer real value to healthcare professionals, payers and patients. Norgine&rsquo;s approach and infrastructure is integrated and focused upon ensuring that Norgine wins partnership opportunities for growth.</p>
<p>Norgine is headquartered in the Netherlands and its global operations are based in Amsterdam and in Harefield, UK. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites, one in Hengoed, Wales and one in Dreux, France.<br />
For more information, please visit <a href="http://www.norgine.com" target="_blank">www.norgine.com</a></p>
<p>In 2012, Norgine established a complementary business Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit <a href="http://www.norgineventures.com" target="_blank">www.norgineventures.com</a>.</p>
<p>NORGINE and the sail logo are trademarks of the Norgine group of companies.</p>
<p>
<strong>About Arc Medical Design Ltd.</strong><br />
Providing award-winning and innovative products worldwide, Arc Medical is leading the way in increasing Adenoma Detection Rates (ADR) and improving retrieval methods.
</p>
<p>As a clinician driven company, Arc Medical is uniquely positioned to understand the needs of those working in the gastro-intestinal sector and strives to improve physician experience and patient outcome.</p>
<p>ENDOCUFF and ENDOCUFF VISION are registered trademarks of Arc Medical Design Ltd.</p>
<p>
<strong>Olympus Media Contacts:</strong><br />
Mark Miller, T: +01 484-896-3020 , E: <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a><br />
Michael Levey, T: +01 484-896-5120, E: <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a><br />
</p>
<p>
<strong>Norgine Media Contacts:</strong><br />
Isabelle Jouin, T: +44 (0)1895 453643<br />
Charlotte Andrews, T: +44 (0)1895 453607<br />
Follow us @norgine<br />
</p>
<p>
<strong>Arc Medical Design Ltd Contact:</strong><br />
Tas Javed: T: +44 (0)113 242 0131
</p>
<div style="clear:both;"></div>
<hr />
<p style="font-size:80%;"><sup><a name="i">i</a></sup> Douglas Corley paper (314, 872)</p>
<p style="font-size:80%;"><sup><a name="i">ii</a></sup> Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403</p>
<div style="clear:both;"></div></div></div></div>Wed, 26 Apr 2017 13:21:38 +0000Jason.Lee2756 at https://medical.olympuscanada.comOlympus Awarded Innovative Technology Designation for Three Products at Novation Innovative Technology Expohttps://medical.olympuscanada.com/articles/olympus-awarded-innovative-technology-designation-three-products-novation-innovative
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Annual event identifies healthcare products that improve patient outcomes<br />
and enhance patient and provider safety</em></p>
<p><strong>CENTER VALLEY, Pa.</strong> <strong>(January 28, 2015)</strong> &ndash; Olympus, a precision technology leader in designing and delivering innovative solutions in medical and surgical products, among other core businesses, announced today that three of its products were awarded the Innovative Technology designation by Novation, the nation&rsquo;s leading health care services company for more than 100,000 members and affiliates of VHA Inc., UHC, Children&#39;s Hospital Association&nbsp;and Provista. Those products include the <em>DIEGO</em><sup>&reg;</sup>&nbsp;<em>ELITE</em>&nbsp;Multidebrider<sup>&reg;</sup>, BF-P190 peripheral bronchoscope and Olympus 3D versus Robotic Surgery Cost Comparison Calculator. The products were awarded the coveted Innovative Technology designation at Novation&rsquo;s Innovative Technology Expo on Sept. 10, 2014, at the Irving Convention Center in Irving,&nbsp;Texas.</p>
<p><strong>About Olympus&rsquo; Three Products Awarded Novation&rsquo;s Innovative Technology Designation:</strong></p>
<ul>
<li><a href="/products/diego-elite-multidebrider?utm_source=PRNewswire&amp;utm_medium=press_release&amp;utm_campaign=Novation"><strong>DIEGO</strong><strong><sup>&reg;</sup></strong><strong>&nbsp;ELITE&nbsp;Multidebrider<sup>&reg;</sup></strong></a>: is the world&rsquo;s only ENT system to offer both monopolar and bipolar energy blades for hemostasis &ndash; as well as traditional standard shaver blades &ndash; providing specialists with a full array of surgery options using just one device. Applications for the Olympus DIEGO<sup>&reg;</sup> ELITE include sinus surgery, polypectomy, tonsillectomy, adenoidectomy, inferior turbinate reduction, and laryngeal applications. Procedures powered by the Olympus DIEGO<sup>&reg;</sup> ELITE Multidebrider offer significantly shorter surgery times compared to those performed using standard blades.</li><BR>
<li><a href="/products/bronchoscope/evis-exera-iii-bf-p190?utm_source=PRNewswire&amp;utm_medium=press_release&amp;utm_campaign=Novation"><strong>BF-P190</strong></a><strong>:</strong> the fully rotatable, ultra-slim design of the Olympus BF-P190 bronchoscope, along with its improved tip angulation, advances maneuverability to provide better access in peripheral airways. The bronchoscope also delivers the industry&#39;s largest working channel (2.0 mm) available in a slim 4.2 mm true videoscope, making it ideal for accommodating a variety of endoscopic devices.</li><BR>
<li><strong>Olympus 3D versus Robotic Surgery Cost Comparison Calculator: </strong>demonstrates the potential benefits and cost savings of Olympus<a href="/products/endoeye-flex-3d?utm_source=PRNewswire&amp;utm_medium=press_release&amp;utm_campaign=Novation"> ENDOEYE FLEX 3D Video System</a> (awarded the Innovative Technology designation by Novation in 2013) versus a Surgical Robot System. Not every procedure is suited for a Robot but could still benefit from 3D visualization. The calculator generates a customized cost savings report based on actual facility data.</li><BR>
</ul>
<p>&ldquo;The Innovative Technology designation process identifies products that are used in the direct clinical care of patients and offer an incremental benefit to patient care, or patient or health care worker safety,&rdquo; said Olya Carter, RN and Senior Clinical Manager at Novation. <em>&ldquo;</em>We are excited about the potential the Olympus&rsquo; DIEGO<sup>&reg; </sup>ELITE Multidebrider<sup>&reg;</sup>, BF-P190 peripheral bronchoscope and Olympus 3D versus Robotic Surgery Cost Comparison Calculator have to help hospitals in their efforts to improve patient care.&rdquo;</p>
<p>The three Olympus products were awarded the Innovative Technology designation following a review by more than 200 attendees from hospitals around the United States who serve on a Novation council or task force and participated in the Expo.&nbsp;These key opinion leaders indicated Olympus&rsquo; DIEGO<sup>&reg;</sup> ELITE Multidebrider<sup>&reg;</sup>, BF-P190 peripheral bronchoscope and Olympus 3D versus Robotic Surgery Cost Comparison Calculator offered incremental benefit over other products available on the market.</p>
<p>&ldquo;We are pleased to receive the Innovative Technology designation for these three products and provide the members served by Novation with several &lsquo;world&rsquo;s first&rsquo; products that are advancing patient care,&rdquo; said Richard Reynolds, Executive Vice President of Sales, Marketing and Shared Services of the Medical Systems Group at Olympus Corporation of the Americas. &ldquo;Olympus is committed to helping healthcare facilities address the triple aim of healthcare reform by improving clinical outcomes, reducing overall costs and enhancing patient experience.&rdquo;</p>
<p>This new designation also will identify Olympus&rsquo; three products as designated Innovative Technology products within Novation&rsquo;s online contract catalog, which is accessible by the more than 100,000 members and affiliates of VHA Inc., UHC, Children&#39;s Hospital Association, and Provista served by Novation.&nbsp;This heightened visibility will encourage further consideration by members accessing this agreement.&nbsp;</p>
<p>To learn more about Novation&#39;s Innovative Technology program, visit <a href="http://www.novationco.com/expertise/technology" target="_blank">www.novationco.com/expertise/technology</a>.&nbsp;</p>
<p align="center">###</p>
<p><strong>About Olympus Medical Systems Group </strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures and innovative diagnostic and therapeutic endoscopy, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="/">www.medical.olympusamerica.com</a>.</p>
<p><strong>About Novation, Recipient of the Ethisphere Institute&rsquo;s Ethics Inside Certification </strong></p>
<p>Novation is the nation&rsquo;s leading health care services company, focused on revolutionizing operational performance for more than 100,000 members and affiliates of VHA Inc., UHC, Children&#39;s Hospital Association&nbsp;and Provista LLC.&nbsp;Novation&rsquo;s progressive approach to cost performance, data and intelligence, and integrated advisory solutions helps health care providers envision and advance new models of cost-effective, high-quality care.&nbsp;Headquartered in Irving, Texas, Novation is committed to the highest standards of ethical behavior and twice has been honored with the Ethisphere Institute&rsquo;s coveted Ethics Inside<sup>&reg;</sup> Certification, and has been named three years consecutively to Ethisphere&rsquo;s World&rsquo;s Most Ethical Companies list. To learn more about Novation, please visit <a href="http://www.novationco.com/" target="_blank">novationco.com</a> and follow <a href="http://twitter.com/novationnews" target="_blank">@NovationNews</a> on Twitter.</p>
</div></div></div>Wed, 28 Jan 2015 14:30:11 +0000joshua.boltz@olympus.com2655 at https://medical.olympuscanada.comFDA Clears Olympus’ Narrow Band Imaging® (NBI) for Effective Targeting of Bladder Cancer Biopsies and Improved Visualization of Tumor Marginshttps://medical.olympuscanada.com/articles/fda-clears-olympus%E2%80%99-narrow-band-imaging%C2%AE-nbi-effective-targeting-bladder-cancer-biopsies
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p></p><center><em>Studies show NBI visualizes Non-Muscle-Invasive Bladder Cancer (NMIBC) lesions in additional 17 percent of patients and 24 percent additional tumors – a turning point for identifying the costly, recurrent disease that has affected 535,000 <sup><a href="#i">[i]</a></sup> people in the U.S.</em></center>
<p><strong>CENTER VALLEY, Pa., (December 15, 2014)</strong> – Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today FDA 510(k) clearance of <a href="/technology/nbi-urology?utm_source=medical_website&amp;utm_medium=press_release&amp;utm_campaign=nbi_bladder_cancer">Narrow Band Imaging</a>® (NBI) as enabling effective targeting of biopsies not seen under white light and improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients.</p>
<p>Based on a weighted average, the aggregated FDA-reviewed studies <sup><a href="#ii">[ii]</a></sup> show NBI has visualized NMIBC lesions in:</p>
<ul><li>17 percent additional patients when compared with white light</li>
<li>24 percent additional tumors</li>
<li>28 percent additional carcinoma in situ (CIS or difficult-to-detect flat lesions)</li>
</ul><p>This finding provides new treatment opportunities for urologists both in-office and in the O.R. Additionally, it offers the potential for improved cost reduction and better patient outcomes resulting from earlier detection.</p>
<p>NBI is the world’s only patented endoscopic light technology that enables effective targeting of biopsies not seen under white light without the use of dyes or drugs. NBI is not intended to replace histopathological sampling as a means of diagnosis. NBI enhances visibility of vascular structures on the mucosal surface. Unlike white light, which uses all colors in the spectrum, NBI uses only blue and green. Blue and green light are strongly absorbed by blood and appear darker than normal tissue. Blue light (415nm) highlights the shallow capillaries and green light (540nm) highlights deeper veins. NBI’s potential visualization of bladder cancer symptoms has been acknowledged by the medical community, but in 2013 a meta-analysis reviewed more than 30 disparate studies on the topic, enough to submit to the FDA.</p>
<p>“The detection of occult lesions in patients with de novo and recurrent bladder cancer results in markedly improved outcomes,” said Daniel Canter, M.D., Vice Chairman of the Urologic Institute of Southeastern Pennsylvania and the Department of Urology of the Einstein Healthcare Network and Associate Professor at The Fox Chase Cancer Center. “An improved view into the underlying vascularity of the lining of the bladder means an improved ability to detect and treat not just the visible, obvious tumors but also the lesions that may have been missed with traditional white light cystoscopy only. This is something most urologists have known and would agree with, but it is now backed by the FDA, which should translate into improved patient care.”</p>
<p>Bladder cancer is the sixth most common cancer in the United States <sup><a href="#iii">[iii]</a></sup>, with the highest lifetime treatment costs per patient of all cancers. <sup><a href="#iv">[iv]</a></sup> White light cystoscopy misses small papillary tumors or CIS at an estimated rate of 10-20 percent. <sup><a href="#v">[v]</a></sup> Fifty-four percent of patients who go undiagnosed with CIS will progress to muscle invasive disease and require bladder removal (cystectomy) and a urinary diversion or neobladder. <sup><a href="#vi">[vi]</a></sup><sup><a href="#vii">[vii]</a></sup> Ninety-six percent of patients diagnosed early will survive five years later. <sup><a href="#viii">[viii]</a></sup> Bladder cancer is known to recur 50 percent of the time.</p>
<p><strong>Indications for Use in Office/Clinic as well as Treatment in the O.R.</strong></p>
<p>NBI can be used for NMIBC in the office/clinic for cystoscopy (diagnosis) and in the O.R. or ambulatory surgical center for resection (tumor removal or Transurethral Resection of Bladder Tumor [TURBT]).</p>
<p>In-office, NBI provides new advantages to physicians because the most effective targeting technologies to-date could only be used in the O.R. and could only be used a single time per patient. With NBI, small tumors may be fulgurated in-office and prevent O.R. visits if visualized early enough, reducing costs associated with a costly-to-treat disease. In addition, NBI does not require the patient to take drugs or experience the discomfort of maintaining a full bladder compared with some treatments. NBI is available in both flexible and rigid endoscopes with no contra-indications. From the patient’s perspective, the equipment that uses NBI is the same as typical imaging equipment.</p>
<p>In the O.R., NBI can be used prior to resection to enable effective targeting of biopsies not seen under white light. During resection, NBI can be used to enhance visibility of tumor margins. By enhancing visibility of lesion boundaries, surgeons may be able to perform a more complete resection. Unlike technologies without FDA indications that strip out colors after taking the image with white light, NBI is filtered at the light source to allow application of only blue and green, for a deeper enhancement of vasculature.</p>
<p>The incorporation of NBI into the treatment of bladder cancer helps facilities address key requirements of healthcare reform:</p>
<ul><li><strong>Increased Quality of Care</strong> – Improved visualization of lesions at cystoscopy can lead to earlier intervention, which may help patients avoid more invasive forms of treatment. NBI can be used at initial cystoscopy and throughout patient management and follow-up.</li>
<li><strong>Decreased Costs</strong> – NBI is integrated into the existing video platform, with no change to the office/clinic or O.R. workflow. Early diagnosis and treatment in-office may reduce the number of costly O.R. procedures. Bladder cancer currently has the highest lifetime treatment costs per patient of all cancers. <sup><a href="#ix">[ix]</a></sup></li>
<li><strong>Enhanced Patient Satisfaction</strong> – Patients whose physicians use NBI may experience reduced treatment discomfort during treatment and avoid more invasive forms of the disease that lead to bladder removal and creation of a neo-bladder.</li>
</ul><p>“We are excited to offer NBI to the urologic community and share this new development with primary care physicians who can refer patients to urologists using NBI,” said Richard Reynolds, Executive Vice President – Sales, Marketing &amp; Shared Services of the Medical Systems Group at Olympus Corporation of the Americas. “We believe that NBI has the potential to revolutionize how bladder cancer is detected and treated, helping our customers meet the triple aim of healthcare reform by improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>In addition to urology, NBI has clinical applications throughout the anatomy including gastroenterology, pulmonary and rhinolaryngology (ENT). Olympus has received FDA-clearance for the screening and surveillance of Barrett’s esophagus and is currently exploring other claims for NBI both in gynecology and general surgery.</p>
<p>Olympus has developed an NBI urology app for physicians, available in the App Store with the “Olympus NBI” search terms. The app includes 28 clinical case images, a technology overview, comparison shots of white light and NBI, with an interactive slider and the option to email a case summary to a consulting physician, staff member or patient. To learn more about NBI, visit: <a href="/technology/nbi-urology?utm_source=medical_website&amp;utm_medium=press_release&amp;utm_campaign=nbi_bladder_cancer">medical.olympusamerica.com/nbi-urology</a>.</p>
<p>For more information or to evaluate NBI, please contact your Olympus representative or call 800-848-9024.</p>
<p><strong>About Olympus Medical Systems Group</strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="/?utm_source=medical_website&amp;utm_medium=press_release&amp;utm_campaign=nbi_bladder_cancer">medical.olympusamerica.com</a>.</p>
<hr /><p style="font-size:80%;"><sup><a name="i" id="i">i</a></sup> Bladder Cancer Statistics. American Bladder Cancer Society. Dalton, MA. <a href="http://bladdercancersupport.org/component/content/article/88-accessible-pages/308-bladder-cancer-statistics.html" target="_blank">http://bladdercancersupport.org/component/content/article/88-accessible-pages/308-bladder-cancer-statistics.html</a></p>
<p style="font-size:80%;"><sup><a name="ii" id="ii">ii</a></sup> Li, K., Lin, T., Fan, X., Duan, Y., &amp; Huang, J. (2013). Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: A systematic review and meta-analysis. International Journal of Urology, 20, 602-609. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23113702" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/23113702</a></p>
<p style="font-size:80%;"><sup><a name="iii" id="iii">iii</a></sup> SEER Cancer Statistics Factsheets: Bladder Cancer. National Cancer Institute. Bethesda, MD, <a href="http://seer.cancer.gov/statfacts/html/urinb.html" target="_blank">http://seer.cancer.gov/statfacts/html/urinb.html</a></p>
<p style="font-size:80%;"><sup><a name="iv" id="iv">iv</a></sup> Sievert, K., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., Stenzl, A. (Jun 2009). Economic aspects of bladder cancer: What are the benefits and costs? World Journal of Urology, 27(3), 295-300. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694315/" target="_blank">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694315/</a></p>
<p style="font-size:80%;"><sup><a name="v" id="v">v</a></sup> Jichlinski, P., &amp; Leisinger, H. (2005). Fluorescence Cystoscopy in the Management of Bladder Cancer: A Help for the Urologist! Urologia Internationalis, 74(2), 97-101. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15756058" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/15756058</a></p>
<p style="font-size:80%;"><sup><a name="vi" id="vi">vi</a></sup> Sylvester, R., Meijden, A., Witjes, J., Jakse, G., Nonomura, N., Cheng, C. Kurth, K. (2005). High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology, 66: 90–107 (Originally reference 29 of Li meta analysis). <a href="http://www.ncbi.nlm.nih.gov/pubmed/16399418" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/16399418</a></p>
<p style="font-size:80%;"><sup><a name="vii" id="vii">vii</a></sup> Li, K., Lin, T., Fan, X., Duan, Y., &amp; Huang, J. (2013). Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: A systematic review and meta-analysis. International Journal of Urology, 20, 602-609. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23113702" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/23113702</a></p>
<p style="font-size:80%;"><sup><a name="viii" id="viii">viii</a></sup> SEER Cancer Statistics Factsheets: Bladder Cancer. National Cancer Institute. Bethesda, MD, <a href="http://seer.cancer.gov/statfacts/html/urinb.html" target="_blank">http://seer.cancer.gov/statfacts/html/urinb.html</a></p>
<p style="font-size:80%;"><sup><a name="ix" id="ix">ix</a></sup> Sievert, K., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., Stenzl, A. (Jun 2009). Economic aspects of bladder cancer: What are the benefits and costs? World Journal of Urology, 27(3), 295-300. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694315/" target="_blank">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694315/</a></p>
<p style="font-size:80%;">* Dr. Canter is a paid consultant of Olympus.</p>
</div></div></div>Fri, 12 Dec 2014 19:57:56 +0000rnunamaker2644 at https://medical.olympuscanada.comOlympus Expands VisiGlide Guidewire Lineup to Deliver Full Spectrum Solution for Endoscopies in the Biliary Tracthttps://medical.olympuscanada.com/articles/olympus-expands-visiglide-guidewire-lineup-deliver-full-spectrum-solution-endoscopies
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p></p><center>
<p><em>Newest VisiGlide 2TM Guidewire from Olympus Delivers Precise Handling for<br />
Therapeutic Work in Sensitive Anatomy</em></p>
<p></p></center>
<p><strong>CENTER VALLEY, Pa., (October 20, 2014)</strong> – Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the commercial availability of its 510(k) cleared, single-use <a href="/products/guidewires/visiglide-2-guidewires">VisiGlide 2</a> guidewires. Designed for use in endoscopic treatment of the biliary and pancreatic ducts, the enhanced flexibility of VisiGlide 2 tip makes this guidewire ideal for difficult cannulations and tight anatomy during biliary endoscopies.</p>
<p>Biliary endoscopy, or endoscopic retrograde cholangiopancreatography (ERCP), is a procedure that combines endoscopy and fluoroscopy (internal imaging to obtain real-time, moving X-ray images of internal structures). ERCP enables physicians to diagnose and treat problems in the gallbladder, bile ducts, pancreas and liver, such as gallstones, strictures, leaks resulting from trauma or surgery, and cancers. According to Truven Health Analytics data, more than 559,000 ERCP procedures were performed in the United States in 2012. <sup><a href="#edn1">[i]</a></sup> During ERCP, guidewires are frequently used to obtain initial access to a target duct or confined space and then help advance bulkier devices to the desired location.</p>
<p>"The navigational ability of the VisiGlide 2 exceeds any wire that I've used previously,” said Dr. David Diehl, Director of Interventional Endoscopy, Geisinger Medical Center, Danville, PA. “The tip can negotiate difficult strictures, and with its one-to-one torque control, I can directly steer the wire exactly where I want it to go."</p>
<p>Olympus <a href="/products/visiglide-guidewires">VisiGlide guidewires</a> are part of the innovative <a href="/products/v-system">V-System</a>, designed to enhance the success rate of ERCP. These guidewires include advanced fluoroscopic and endoscopic markings to assist with stricture measurement and a hydrophilic tip improves ductal navigation. Both 0.025- and 0.035-inch guidewires are available in 270 cm and 450 cm working lengths, with both straight and angled tips.</p>
<p>Coupled with the same high-performance hydrophilic coating of the standard VisiGlide, the VisiGlide 2 provides optimal tip flexibility for smooth ductal navigation, reducing risk of tissue trauma and making it an excellent choice for pancreatic anatomy. It can be used for guiding and exchanging endoscopic accessories in the biliary system, including the common bile, cystic, pancreatic and right and left hepatic ducts. The VisiGlide 2 is also safe to use during sphincterotomy.</p>
<p>Key features of the VisiGlide 2 include:</p>
<ul><li><strong>Precise Control</strong>: A flexible tip paired with Terumo’s Glidewire coating provides excellent navigation for tight ductal anatomy, such as strictures and pancreatic ducts.</li>
<li><strong>Atraumatic Design</strong>: A tapered core wire at the hydrophilic distal tip provides optimal flexibility and soft tissue contact to work well in sensitive anatomy.</li>
<li><strong>Excellent Torque</strong>: One-to-one torque control as well as a tapered hydrophilic tip aid in guidewire navigation and selective duct insertion. The angled tip version of VisiGlide 2 further enhances control during delicate procedures.</li>
<li><strong>Signature Brand Features</strong>: VisiGlide 2 maintains the key features of the VisiGlide product line, including a 0.025-inch diameter with the stiffness of a 0.035-inch guidewire, highly visible radiopaque and endoscopic markings, and proprietary coatings.</li>
</ul><p>"We are very excited to launch the VisiGlide 2 ERCP guidewire to handle the complex challenges encountered during advanced biliary endoscopies,” said Rick Harbuck, Group Vice President at Olympus America Inc. “Our expanded line of VisiGlide guidewires provide physicians with the specific tools they need for therapeutic treatment in the biliary and pancreatic ducts to help ensure the best procedural outcomes. Designed with performance and patient safety in mind, these tools can help facilities address the requirements of healthcare reform aimed at improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>Olympus VisiGlide 2 guidewires will be showcased October 19 at the ACG 2014 Annual Scientific Meeting and Postgraduate Course held in Philadelphia, Pa.</p>
<p>For more information about VisiGlide 2, please contact Olympus customer service at 1-800-848-9024 or visit <a href="/products/guidewires/visiglide-2-guidewires">medical.olympusamerica.com/products/guidewires/visiglide-2-guidewires</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://medical.olympusamerica.com/">medical.olympusamerica.com</a>.</p>
<hr align="left" size="1" width="100%" /><p><span style="font-size:10px;"><a id="edn1" name="edn1" style="color:#000000;"></a><sup>[i]</sup> Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</span></p>
<p><span style="font-size:10px;">*Dr. Diehl is a paid consultant of Olympus.</span></p>
</div></div></div>Mon, 20 Oct 2014 14:00:11 +0000rnunamaker2620 at https://medical.olympuscanada.comOlympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Markethttps://medical.olympuscanada.com/articles/olympus-partners-brainlab-exclusive-distributor-ent-products-us-market
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p></p><center><em>Brainlab Kick<sup>®</sup> Navigation ENT aids in complex surgeries and integrates seamlessly with Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup> for tissue dissection with hemostasis</em></center>
<p><strong>CENTER VALLEY, Pa. (September 22, 2014)</strong> – Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today it has reached a deal with Munich-based Brainlab to be the exclusive U.S. distributor of Kick<sup>®</sup> Navigation. This agreement applies to the US ENT market; Brainlab will maintain distribution for cross-disciplinary U.S. sales and all distribution outside the U.S. The system, offering both optical and electromagnetic guidance options, offers surgeons advanced image enrichment and visualization for complex ENT surgeries.</p>
<p>Surgical navigation — also called image-guided surgery, computer-assisted surgery, or software-guided surgery — is similar in concept to a GPS system used in today’s electronic devices. It is designed to continuously track surgical instrumentation relative to the patient’s anatomy and display the relationship in real time on a monitor during surgery. Navigational assistance becomes critical during complex ENT surgeries where instruments are used in close proximity to the optical nerve, the brain and other sensitive tissues.</p>
<p><strong><em>ENT Navigation</em></strong><br />
Navigation software is used to perform intricate surgeries such as sinus and intranasal surgeries, maxillary antrostomies, ethmoidectomy surgery, spheno-idotomies/sphenoid explorations, transphenoidal surgery, tumor resection, turbinate reduction, frontal and lateral skull base as well as pursue interdisciplinary approaches with neurosurgery or CMF departments.</p>
<p>According to Truven Health Analytics Inc., there were more than 4,900,000 sinus procedures performed in the United States in 2012, and more than 75,000 of those surgeries were performed using navigation software <sup><a href="#edn1">[i]</a></sup>.</p>
<p>“Selecting Olympus as the exclusive distributor in the U.S. ENT market for Kick<sup>®</sup> Navigation was a natural choice,” said Sean Clark, President, at Brainlab Inc. “Olympus has a significant presence and stellar reputation in the U.S. ENT marketplace. Integration has been developed between the Olympus DIEGO<sup>®</sup> ELITE system and Kick<sup>®</sup> Navigation. The combination of the two systems enables surgeons to perform some of the most complex and advanced ENT surgeries available today.”</p>
<p>Brainlab Kick<sup>®</sup> Navigation Technology</p>
<p>Brainlab Kick<sup>®</sup> features intuitive user interfaces, optimized workflows, advanced imaging and tailored software integration, which helps clinicians leverage available information. Brainlab ENT platforms are available with both optical (Kick<sup>®</sup>) and electromagnetic (Kick<sup>®</sup> EM) surgical instrument tracking technology. Both versions deliver advanced 3D displays, user-friendly touch-based and touchless patient registration options and real-time virtual anatomy updates.</p>
<p>The Brainlab software offers universal tool integration and an open platform for surgeons to use the implant and tool manufacturers of their choice, but integrates seamlessly with the Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup>.</p>
<p><strong>Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup></strong><br />
The Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup> is the world’s only ENT system to offer both monopolar and bipolar energy blades as an option to control bleeding — as well as traditional standard shaver blades — providing specialists with a full array of surgery options using just one device.</p>
<p>“The Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup> is ideal for all types of sinus and endoscopic skull base surgery. Its versatility reduces the need for instrument exchanges and allows me to get to the source of bleeding instantly,” said Alexander Chiu, MD, Professor and Chair, Otolaryngology-Head and Neck Surgery at the University of Arizona and member of the DIEGO<sup>®</sup> ELITE evaluation team. “Now the ability to add Brainlab navigation to this system will enable surgeons to perform complex ENT surgeries while increasing procedural efficiency."</p>
<p>“Brainlab Kick<sup>®</sup> systems are an important addition to our portfolio of ENT surgical products,” said Richard Reynolds, Executive Vice President - Sales, Marketing &amp; Shared Services of the Medical Systems Group at Olympus Corporation of the Americas. “Innovations like the Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup> along with Kick<sup>®</sup> Navigation allow us to further our commitment to enabling high-quality health care required under Affordable Care.”</p>
<p>The Brainlab Kick<sup>®</sup> ENT systems along with the Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup> are being showcased at the American Association of Otolaryngology - Head &amp; Neck Society (AAO-HNSF) Annual Meeting &amp; OTO Expo, September 21-24, 2014, in Orlando, Fla.</p>
<p>For more information or to evaluate the Brainlab Kick<sup>®</sup> ENT system or the Olympus DIEGO<sup>®</sup> ELITE Multidebrider<sup>®</sup>, please contact your Olympus representative or call 1-800-773-4301. To learn more, visit: <a href="http://medical.olympusamerica.com/products/diego-elite-multidebrider">medical.olympusamerica.com/products/diego-elite-multidebrider</a>.</p>
<p><strong>About Brainlab</strong><br />
Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments. Brainlab technology powers treatments in radiosurgery as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma. Founded in Munich in 1989, Brainlab has over 5,000 systems installed in 95 countries.</p>
<p>For more information, visit Brainlab at <a href="http://www.brainlab.com" target="_blank">www.brainlab.com</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<hr align="left" size="1" width="100%" /><p><span style="font-size:10px;"><a id="edn1" name="edn1" style="color:#000000;"></a><sup>[i]</sup> Data for use in this 2012 study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</span></p>
<p><span style="font-size:10px;">*Dr. Chiu is a paid consultant of Olympus.</span></p>
</div></div></div>Fri, 19 Sep 2014 20:31:24 +0000rnunamaker2608 at https://medical.olympuscanada.comOlympus Launches New Hemostasis Clip with Advanced Control for GI Endoscopyhttps://medical.olympuscanada.com/articles/olympus-launches-new-hemostasis-clip-advanced-control-gi-endoscopy
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>QuickClip Pro<sup>TM</sup> Delivers Both Rotational Control and Open and Close Capabilities</em> <em>for Precise Handling and Predictable Performance</em></p>
<p><strong>CENTER VALLEY, Pa., (September 8, 2014)</strong> – Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the commercial availability of its 510(k) cleared <a href="https://medical.olympusamerica.com/products/quickclippro?utm_source=medical_website&amp;utm_medium=press_release&amp;utm_campaign=quickclippro_launch">QuickClip Pro</a>™ hemostasis clip designed for bleed control and defect closure during GI endoscopy procedures.</p>
<p>Unlike prior generation clip fixing devices, the QuickClip Pro combines both superior rotational control to ensure precise placement along with the addition of open and close capabilities for easy repositioning. The importance of the rotation ability is due to the fact that clips often do not come out of the scope in the right orientation, making it challenging to manipulate the clip to the correct angle that would successfully stop a bleed or close a defect.</p>
<p>“I have found the QuickClip Pro to be superior in some features to the other clips on the market,” said Dr. Norio Fukami, Associate Professor of Medicine at University of Colorado. “In a retroflexed scope position, it can be inserted and rotated smoothly, and it is strong enough to close large defects. Tissue approximation appears smooth with less slipping. Because the clip functions well in various scope positions, it would be ideal for complex cases and accessing difficult areas.”</p>
<p>There are more than 22.5 million upper and lower outpatient GI endoscopy procedures performed in the United States annually<sup><a href="#edn1">[i]</a></sup> with approximately 527,000 clips placed during these procedures. Endoscopic clipping represents the fastest growing market for GI endoscopy hemostasis with an annual sales volume of $75.3 million expected in 2014.<sup><a href="#edn1">[ii]</a></sup></p>
<p>Endoscopic clipping is considered to be one of the simplest and most reliable hemostatic techniques and works by mechanically binding blood vessels to minimizing the risk of re-bleeding and damage to the surrounding tissue while providing instant visual feedback to confirm placement. In addition to hemostasis for mucosal/submucosal defects, bleeding ulcers, arteries, polyps and diverticula in the colon, hemostatic clips can also be used for endoscopic marking and as a supplementary method for closure of some GI tract luminal perforations.</p>
<p>To advance hemostatic technique, the Olympus QuickClip Pro offers all the same signature innovations found on prior generation Olympus clips as well as new advances designed to save procedure time, reduce costs and improve outcomes:</p>
<ul><li>The predictable performance of the clips, even in a fully angulated scope, ensures procedural efficiency.</li>
<li>The proprietary sheath and clip design minimize the potential for channel damage, helping reduce repair-related expenditures.</li>
<li>The clip materials are stronger than stainless steel and tested to remain in place for 14 days for improved procedural outcomes.<sup>*</sup></li>
</ul><p>QuickClip Pro clips are designed for use with Olympus endoscopes to address the clipping needs for both upper and lower GI endoscopy.</p>
<p>“As the pioneer in endoscopic clipping, Olympus is committed to maximizing the efficacy of mechanical hemostasis in GI endoscopy,” said Rick Harbuck, Group Vice President of the Endoscopy Division at Olympus America Inc. “By effectively delivering more precise control and placement, QuickClip Pro clips can help facilities meet the requirements of healthcare reform aimed at improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>Specific advantages of QuickClip Pro in meeting the triple aim of healthcare reform include:</p>
<ul><li><strong>Quality of care:</strong> Rotational control and open and close functionality allow precise placement and control of the clip, delivering more confidence in treatment with the potential to reduce the risk of complications.</li>
<li><strong>Decrease costs</strong>: With easier insertion and placement even in complex cases, the clip can help speed up procedures. Extra durable arms with an opening width of 11 mm ensure the clip can reliably cover larger areas and be placed further apart.</li>
<li><strong>Enhanced patient satisfaction</strong>: With proven performance, QuickClip Pro clips have the potential to reduce the risk of complications from hemostasis, potentially allowing patients to be released from care more quickly.</li>
</ul><p>The QuickClip Pro will be showcased at ASGE’s EndoFest 2014 September 19-21 in Las Vegas, Nev. (Booth #9), and at the ACG 2014 Annual Meeting October 17-22 in Philadelphia, Pa. (Booth #727). Physicians are invited to stop by the Olympus booths at both shows to see the latest advances in hemostatic clipping.</p>
<p>For more information about the QuickClip Pro, please contact Olympus customer service at 866-888-1950, or visit us at <a href="https://medical.olympusamerica.com/products/quickclippro?utm_source=medical_website&amp;utm_medium=press_release&amp;utm_campaign=quickclippro_launch">medical.olympusamerica.com/products/quickclippro</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com/">www.medical.olympusamerica.com</a>.</p>
<hr align="left" size="1" width="100%" /><p><span style="font-size:10px;"><a id=" edn1" name="edn1" style="color:#000000;"><sup>[i]</sup> Data for use in this 2012 study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</a></span></p>
<p><a id="edn2" name="edn2" style="color:#000000;"></a><sup>[ii]</sup> <span style="font-size:10px;">US Markets for Gastrointestinal Endoscopy Devices 2014, RPUS30GI14, 2014 Millennium Research Group, Inc. All rights reserved. Reproduction, distribution, transmission or publication is prohibited. Reprinted with permission.</span></p>
<p style="padding-top:15px;"><span style="font-size:10px;">Olympus funded clinical studies managed by Dr. Fukami to confirm the safe &amp; effective use of this product.</span></p>
<p><span style="font-size:10px;"><sup>*</sup> FDA reviewed simulated testing on file.</span></p>
</div></div></div>Fri, 05 Sep 2014 20:30:02 +0000rnunamaker2607 at https://medical.olympuscanada.comOlympus’ ENDOEYE FLEX 3D Articulating Videoscope Receives Breakthrough Innovation Technology Award at Premier, Inc.’s 2014 National Breakthroughs Conferencehttps://medical.olympuscanada.com/articles/olympus%E2%80%99-endoeye-flex-3d-articulating-videoscope-receives-breakthrough-innovation
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>World’s Only Articulating HD 3D Laparoscopic Surgical Video System Improves Speed,<br />
Accuracy and Precision When Compared to 2D Systems </em></p>
<p><strong>CENTER VALLEY, Pa., June 11, 2014</strong> – Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions for medical and surgical procedures, among other core businesses, announced today that its<a href="http://medical.olympusamerica.com/?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=Endoeye_Premier"> ENDOEYE FLEX 3D</a> articulating videoscope was one of 16 medical innovations on display in front of thousands of healthcare providers and experts at the at the <a href="http://www.premierinc.com/breakthroughs">Premier, Inc. 2014 Breakthroughs Conference and Exhibition</a>.</p>
<p>Olympus’ 3D Imaging System was showcased during the conference’s sixth annual <a href="https://www.premierinc.com/breakthroughs/conference-overview/special-events/">Innovation Celebration</a>, which recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.</p>
<p>“We are honored to be recognized by Premier for innovative technology that will help physicians and surgeons improve the overall care of their patients," said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “Olympus is fully committed to helping healthcare facilities fulfill the requirements of healthcare reform aimed at improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>Olympus’ ENDOEYE FLEX 3D is the world's only articulating HD 3D videoscope. The system’s 3D visualization provides depth perception and a precise spatial view of anatomy that cannot be achieved with traditional 2D systems, producing bright, natural 2D and 3D images in a lightweight and ergonomic design. It also delivers up to 100 degrees of articulation in all directions, enabling observation and therapy in the entire peritoneal cavity — and with a level visual horizon.</p>
<p>When compared with traditional 2D surgical systems, the ENDOEYE FLEX 3D delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing, based on internal Olympus testing conducted using a simulated surgical model.* Olympus’ 3D system also provides surgeons with real time tactile feedback, which is lost when using robotic alternatives.</p>
<p>The modular design of the Olympus 3D Imaging System makes it easy to add 3D capability to existing Olympus EVIS EXERA III universal imaging systems, reducing the investment necessary to add 3D capability. The EVIS EXERA III system is compatible with more than 100 endoscopes and camera heads. This compatibility is retained even after upgrading to 3D, helping to reduce capital investments and simplify asset management and training. Olympus 3D Imaging also is seamlessly integrated into the <a href="http://medical.olympusamerica.com/technology/software-system-integration/systems-integration?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=Endoeye_Premier_Tech_Award">Olympus ENDOALPHA Integrated Operating Room</a>.</p>
<p>“Those who attend and participate in the Innovation Celebration share Premier’s commitment to providing valuable products to our members that are safe, high-quality and cost-effective,” said Durral R. Gilbert, president of supply chain services, Premier. “We believe these innovations can benefit providers as they work to transform healthcare.”</p>
<p>Award winners were announced June 10, 2014, during the Innovation Celebration held at the Henry B. Gonzalez Convention Center in San Antonio, Texas.</p>
<p>For more information or to evaluate the Olympus ENDOEYE FLEX 3D system, please contact your Olympus representative or call 800-548-5515.</p>
<p><strong>About Premier, Inc.</strong><br />
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,000 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on <a href="http://www.premierinc.com/">www.premierinc.com</a>; as well as<a href="https://twitter.com/premierha"> Twitter</a>, <a href="https://www.facebook.com/premierhealthcarealliance">Facebook</a>, <a href="http://LinkedIn">LinkedIn</a>, <a href="https://www.youtube.com/user/premieralliance">YouTube</a>,<a href="http://instagram.com/premierha"> Instagram</a>, <a href="https://foursquare.com/premierha">Foursquare</a> and <a href="http://actionforbetterhealthcare.com/">Premier’s blog</a> for more information about the company.</p>
<p><strong>About Olympus Medical Systems Group </strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<p> *Data on file.</p>
</div></div></div>Wed, 11 Jun 2014 15:55:55 +0000rnunamaker2562 at https://medical.olympuscanada.comOlympus ENDOEYE FLEX 3D Recognized as Breakthrough Technology of the Year at American Technology Awards Showcasehttps://medical.olympuscanada.com/articles/olympus-endoeye-flex-3d-recognized-breakthrough-technology-year-american-technology-awards
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p></p><center><em>World’s Only Articulating HD 3D Videoscope Advances Laparoscopy<br />
With Improved Speed, Accuracy and Precision</em></center>
<p><strong>CENTER VALLEY, Pa., June 5, 2014</strong> – Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions for medical and surgical procedures, among other core businesses, announced today that its <a href="http://medical.olympusamerica.com/products/laparoscopes/endoeye-flex-3d">ENDOEYE FLEX 3D</a> articulating videoscope received top honors as the <a href="http://www.marketwatch.com/story/american-technology-awards-announces-winners-in-15-categories-awards-breakthrough-technology-of-the-year-to-olympus-3d-videoscope-2014-05-21?reflink=MW_news_stmp">Breakthrough Technology of the Year</a>. The recognition, bestowed at the annual American Technology Awards (ATA) Showcase, is presented by TechAmerica, the public sector and public advocacy division of CompTIA.</p>
<p>The ATA Showcase recognizes outstanding achievements in technology in 15 categories and also designates a best innovation overall. Award recipients were announced on May 20 in Washington, D.C. The ENDOEYE FLEX 3D articulating videoscope received awards for top innovations in the Health &amp; Medical Technologies category, as well as the best in show designation.</p>
<p> “Congratulations to all the deserving recipients of the American Technology Awards, and particularly to Olympus for its life-changing innovation in laparoscopic technology," said Todd Thibodeaux, president and chief executive officer, CompTIA.</p>
<p> Olympus is a pioneer of minimally invasive surgery (laparoscopy), a modern technique in which an operation in the abdomen is performed through small incisions as compared to larger incisions needed in traditional surgical procedures. A video laparoscope with a miniature camera built into its tip allows the surgeon to view the surgery site during an operation.</p>
<p>Olympus’ ENDOEYE FLEX 3D is the world's only articulating HD 3D videoscope. The system’s 3D visualization provides depth perception and a precise spatial view of anatomy that cannot be achieved with traditional 2D systems, producing bright, natural 2D and 3D images in a lightweight and ergonomic design. It also delivers up to 100 degrees of articulation in all directions, enabling observation and therapy in the entire peritoneal cavity.</p>
<p>When compared with traditional 2D surgical systems, the ENDOEYE FLEX 3D delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing, based on internal Olympus testing conducted using a simulated surgical model.* Olympus’ 3D system also provides surgeons with real time tactile feedback, which is compromised when using robotic alternatives.</p>
<p> “We are honored to be recognized with a TechAmerica Foundation award for technology that will help physicians and surgeons improve the overall care of their patients," said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “ENDOEYE FLEX 3D will help hospitals and healthcare providers deliver world-class care to their patients through early, minimally invasive diagnosis and treatment of diseases and other conditions.”</p>
<p> Olympus will be presented with the award for the ENDOEYE FLEX 3D at TechAmerica Foundation's Technology and Government Dinner on June 12. The gala event brings together industry, congressional and government leaders to celebrate the partnership between the tech sector and government. At last year's dinner, TechAmerica presented the overall award to Google Glass.</p>
<p>For more information or to evaluate the Olympus ENDOEYE FLEX 3D system, please contact your Olympus representative or call 800-548-5515.</p>
<p><strong>About TechAmerica</strong><br />
TechAmerica is the public sector and public policy division of CompTIA, advocating before decision makers at the state, federal and international levels of government. Representing technology companies of all sizes, TechAmerica is committed to expanding market opportunities and driving the competitiveness of the U.S. technology industry around the world. With offices on Capitol Hill and in Northern Virginia, Silicon Valley and Europe, as well as regional offices around the United States, TechAmerica delivers top-tier business intelligence and networking opportunities on a global scale.</p>
<p> For more information visit TechAmerica at <a href="http://www.techamerica.org">www.techamerica.org</a>. Learn more about CompTIA, the ICT industry trade association, at <a href="http://www.comptia.org">www.comptia.org</a>.</p>
<p><strong>About Olympus Medical Systems Group </strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://medical.olympusamerica.com/?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=Endoeye_ATA">medical.olympusamerica.com</a>.</p>
<p>*Data on file.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Thu, 05 Jun 2014 19:55:23 +0000Kim.Ciesla2561 at https://medical.olympuscanada.comOlympus Launches First HD Single-Channel Therapeutic Gastroscope for Advanced Diagnosis and Treatment of GI Tract https://medical.olympuscanada.com/articles/olympus-launches-first-hd-single-channel-therapeutic-gastroscope-advanced-diagnosis-and
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>New Scope Allows Hospitals to Realize Cost Savings and Efficiencies Through </em><br />
<em>One-Scope Solution for Diagnosis and Therapy</em></p>
<p><strong>CENTER VALLEY, Pa., May 28, 2014</strong> &ndash; Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions for medical and surgical procedures, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation GIF-1TH190 gastrointestinal videoscope for endoscopy or endoscopic surgery use within the upper digestive tract.<br />
<br />
As the first single-channel therapeutic gastroscope to offer both high-definition (HD) and <a href="http://medical.olympusamerica.com/technology/narrow-band-imaging">Narrow Band Imaging</a> capabilities, the GIF-1TH190 provides physicians with the advanced resolution and enhanced imaging needed for screening and diagnosis, along with a large 3.7 mm working channel for therapeutic applications.<br />
<br />
&ldquo;Imaging is increasingly important as we advance our minimally invasive techniques for resection of early neoplastic lesions,&rdquo; said Robert H. Hawes, MD, attending endoscopist at Florida Hospital. &ldquo;If you want to do therapy, you must have optimal imaging. Using the same scope for imaging and therapy is optimal. The new GIF-1TH190 will allow that.&rdquo;</p>
<p>Prior to the GIF-1TH190, HD technology was primarily used in the upper GI tract for diagnostic functions. As physicians shifted from diagnosis to therapy, they switched to a scope with lesser-quality visualization in favor of a larger working channel. The GIF-1TH190 goes beyond the previous technology to allow for excellence in visualization at the same time that therapy is delivered. The decreased size of the imaging chip allows for a narrower insertion tube, while the larger working channel allows for the insertion of dilation balloons, ablation tools, coagulation probes and other devices physicians may want to use.<br />
<br />
The HD and electronically enhanced imaging in the GIF-1TH190 provides sharper contours, more natural colors and greater resolving power for visualization of fine details. The GIF-1TH190 also delivers enhanced Narrow Band Imaging (NBI). NBI is a validated visualization tool for observing capillary and mucosal structures, allowing better observation of dysphasia, metaplasia and inflammation in patients with Barrett&rsquo;s esophagus.</p>
<p>According to Truven Health data, U.S. physicians performed more than 8.6 million upper endoscopy procedures in 2012 <sup>[1]</sup> in an effort to detect, prevent or treat Barrett&rsquo;s esophagus, cancers, lesions and other disorders in the upper digestive tract. Barrett&rsquo;s esophagus, commonly considered to be a precancerous condition, is estimated to affect 1.6 to 6.8 percent of the population. <sup>[2]</sup> Using HD NBI to target suspicious areas in Barrett&rsquo;s&nbsp;esophagus patients can result in significantly fewer biopsies than white light examination with the Seattle protocol<sup>[3]</sup>.&nbsp;</p>
<p>Key features of the GIF-1TH190 include:</p>
<ul>
<li><strong><em>HDTV image quality:</em></strong> HD imaging delivers improved screening and diagnostic capabilities.</li>
<br />
<li><strong><em>Narrow Band Imaging:</em></strong> &nbsp;HD NBI provides contrast, which may aid in the interpretation of mucosal morphology, vascular patterns, and blood vessel appearance in patients with Barrett&rsquo;s esophagus.&nbsp; It also provides nearly twice the viewable distance under NBI compared to previous-generation scopes.</li>
<br />
<li><strong><em>Slim design:</em></strong> The 10.0 mm distal end diameter is 0.9 mm less than the scope&rsquo;s predecessor while maintaining a large 3.7 mm working channel.</li>
<br />
<li><strong><em>Depth of field:</em></strong> The 2-100 mm depth of field allows close examination of the mucosa without the need for magnification.</li>
<br />
<li><strong><em>Water jet:</em></strong> A forward water jet helps keep the mucosa clear during observation and treatment.</li>
<br />
<li><strong><em>Waterproof one-touch connector</em></strong><em>:</em> A new connector simplifies the effort required for setup; its fully submersible design eliminates the need for a water-resistant cap and minimizes the risk of fluid invasion.</li>
<br />
<li><strong><em>EVIS EXERA III universal platform:</em></strong><strong> </strong>The scope is powered by an advanced imaging system, which works seamlessly across specialties to provide easier data management and cost efficiencies.</li>
</ul>
<p>As part of the EVIS EXERA III system, the GIF-1TH190 offers tangible improvements over its predecessor, including an advanced imaging unit, better image processing, noise reduction and reduced halation.<br />
<br />
&ldquo;The GIF-1TH190 offers superb diagnostic capabilities in a therapeutic scope,&rdquo; said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. &ldquo;This allows physicians to use just one instrument to perform both tasks, creating procedural and cost efficiencies. We are committed to helping our customers meet the triple aim of Affordable Care by improving quality of care, decreasing costs and enhancing patient satisfaction.&rdquo;<br />
<br />
Olympus&rsquo; GIF-1TH190 gastrointestinal videoscope was showcased at Digestive Disease Week 2014 earlier this month in Chicago, IL. For more information, please contact your Olympus representative, call 800-848-9024 or <a href="http://medical.olympusamerica.com/products/gastroscope/evis-exera-iii-gif-1th190?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=GIF1th190">visit our GIF-1TH190 web page</a>.</p>
<p><strong>About Olympus Medical Systems Group </strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for health care professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of health care.</p>
<p>For more information, visit Olympus at <a href="http://medical.olympusamerica.com/products/gastroscope/evis-exera-iii-gif-1th190?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=GIF1th190">medical.olympusamerica.com</a>.</p>
<p>[1] Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (&ldquo;Truven Health&rdquo;). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</p>
<div>
<p>[2]&nbsp; &ldquo;Barrett&#39;s Esophagus.&rdquo; NIH Publication No. 13&ndash;4546. National Digestive Diseases Information Clearinghouse (NDDIC). Feb 2013. Web 12 May 2014. <a href="http://digestive.niddk.nih.gov/ddiseases/pubs/barretts/#how" target="_blank">http://digestive.niddk.nih.gov/ddiseases/pubs/barretts/#how</a>
&nbsp;</div>
<p>[3]&nbsp;Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett&rsquo;s esophagus. Gastroenterology 1993; 105:40-50.</p>
</div>
</div>
<div>
<div id="edn2">
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div>
</div>
<p>&nbsp;</p></div></div></div>Thu, 29 May 2014 13:28:54 +0000rnunamaker2560 at https://medical.olympuscanada.comOlympus Receives Three Edison Awards for Healthcare Product Innovationhttps://medical.olympuscanada.com/articles/olympus-receives-three-edison-awards-healthcare-product-innovation
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Company Recognized for Game-Changing Technology in Science/Medicine</em></p>
<p><strong>CENTER VALLEY, Pa., May 15, 2014</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that the company has received Edison Awards for three of its “world’s only" products: ENDOEYE FLEX 3D, THUNDERBEAT and the BF-190 Bronchoscope. All three products were recognized at the awards ceremony in the category of science/medicine.</p>
<p>The distinguished Edison Awards are named after Thomas Alva Edison (1847-1931) whose extraordinary new product development methods and innovative achievements garnered him 1,093 U.S. patents and made him a household name around the world. The ballot of nominees for the Edison Awards was judged by a panel of more than 3,000 individuals, including members of seven different associations representing a wide variety of industries and disciplines.</p>
<p>“It’s exciting to see companies like Olympus continuing Thomas Edison’s legacy of challenging conventional thinking,” said Frank Bonafilia, Edison Awards’ executive director. “Edison Awards recognizes game‐changing products and services, and the teams that brought them to consumers.”</p>
<p>All three Olympus products recognized with Edison Awards represent world’s only innovations for the surgical and medical markets:</p>
<ul><li><a href="http://medical.olympusamerica.com/products/endoeye-flex-3d"><strong>ENDOEYE FLEX 3D</strong></a> – recipient of a Silver award in the Surgical Aids category – is the world’s only articulating HD 3D laparoscopic surgical imaging system, which improves the speed, accuracy and precision of surgical procedures when compared to 2D surgical systems. This is accomplished by restoring a surgeon’s natural 3D vision and depth perception during laparoscopic procedures. The technology is available as a module that can be easily added to an existing Olympus EVIS EXERA III universal imaging system.</li>
<li><a href="http://medical.olympusamerica.com/products/thunderbeat"><strong>THUNDERBEAT</strong></a> – recipient of a Bronze award in the Assistive Devices category – is the world’s only platform that combines advanced bipolar and ultrasonic energies into a single multifunctional instrument. This allows surgeons to simultaneously cut and seal vessels, minimizing instrument exchanges and reducing procedure time. Additionally, it boasts the fastest cutting speed and provides the highest grasping force at the tip when compared to other leading energy instruments.</li>
<li><a href="http://medical.olympusamerica.com/products/bf-190"><strong>BF-190 Bronchoscope</strong></a> – recipient of a Bronze award in the Surgical Aids category – is the world’s only fully rotatable HD bronchoscope, offering unparalleled maneuverability and flexibility through the combination of their unique Rotary Function and wider tip angulation. This advanced maneuverability potentially allows physicians to access areas of the lung that may not be easily reached with current generation bronchoscopes. </li>
</ul><p>“We are honored to be recognized by the Edison Innovation Awards as a company that is developing unique and innovative technology that will help physicians and surgeons improve the overall care of their patients," said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “Olympus is fully committed to helping healthcare facilities meet the requirements of healthcare reform aimed at improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>Award winners were announced April 30, 2014, at the Edison Awards Annual Gala, held in the historic Julia Morgan Ballroom in San Francisco, Calif. </p>
<p><strong>About the Edison Awards</strong><br />
Edison Awards nominees are judged by more than 3,000 senior business executives and academics from across the nation whose votes acknowledge the finalists’ success in meeting the award’s stringent criteria of quality. The Edison Awards is a program conducted by Edison Universe, a 501(c)(3) charitable organization dedicated to fostering future innovators. The 2014 Edison Awards are sponsored by Ipsos.</p>
<p>For more information about the Edison Awards, Edison Universe and a list of past winners, visit <a href="http://www.edisonawards.com">www.edisonawards.com</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://medical.olympusamerica.com?utm_source=PR&amp;utm_medium=press_release&amp;utm_campaign=Edison_2014">medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey<br />
Olympus Corporation of the Americas<br />
484-896-5120<br /><a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Wed, 14 May 2014 19:51:06 +0000joshua.boltz@olympus.com2557 at https://medical.olympuscanada.comNew Frontiers in Lung Disease: Olympus Launches Two New Endoscopes for Peripheral and Small Anatomy Bronchoscopyhttps://medical.olympuscanada.com/articles/new-frontiers-lung-disease-olympus-launches-two-new-endoscopes-peripheral-and-small-anatomy
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Fully Rotatable and Ultra-Slim Bronchoscopes Designed<br />
to Extend Reach Within Tracheobronchial Tree</em></p>
<p><strong>CENTER VALLEY, Pa., May 8, 2014</strong> – Olympus, a precision technology leader in designing and delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation BF-P190 and BF-XP190 bronchoscopes for peripheral and small anatomy bronchoscopy.</p>
<p>Olympus is a pioneer in developing innovative solutions to advance the field of bronchoscopy. In 2012, there were approximately 871,000 bronchoscopies performed in the U.S., based on Truven Health data,<a href="#_edn1" name="_ednref1" title="" id="_ednref1">[i]</a> and bronchoscopy plays a key role in detecting and treating lung cancers. According to the American Cancer Society, lung cancer is the leading cause of all cancer-related deaths in the United States and will claim 159,260 lives in 2014, more than colon, breast and prostate cancers combined.</p>
<p><strong>BF-P190 Extends Reach for Peripheral Bronchoscopy</strong><br />
With new recommendations from the U.S. Preventive Services Task Force calling for more proactive lung cancer screening of long-term smokers, the need for reliable methods of assessing peripheral lung nodules is forecasted to increase.</p>
<p>Transthoracic needle aspiration (TTNA) has long been the gold standard for sampling peripheral pulmonary nodules, but it can present a significant possibility of complications from pneumothorax. In a study by Geraghty et al, 27% (226 out of 846) of CT-guided TTNA biopsy procedures were complicated by pneumothorax.<a href="#_edn2" name="_ednref2" title="" id="_ednref2">[ii]</a> Peripheral bronchoscopy using radial endobronchial ultrasound (EBUS) provides a minimally invasive alternative for sampling peripheral pulmonary nodules suspected of malignancy, with little risk of collapsing the lung. Used solely or in tandem with other modalities, radial EBUS is a proven approach for diagnosing lung cancer and other diseases in the peripheral areas of the lung, and can performed on an outpatient basis under conscious sedation.</p>
<p>The fully rotatable, slim design of the BF-P190 bronchoscope, along with its improved tip angulation, advances maneuverability to provide better access in peripheral airways. The bronchoscope also delivers the industry’s largest working channel (2.0 mm) available in a slim 4.2 mm true videoscope, making it ideal for accommodating a variety of endoscopic devices.</p>
<p>“We're pleased to add the BF-P190 to our practice. The smaller outer diameter of the BF-P190 bronchoscope allows us to go further into the lung periphery, providing better access and visualization of third and fourth generation bronchi. This caliber bronchoscope consistently allows us to reach the mid lung and, in many cases, allows us to be within centimeters of peripheral lung lesions,” said Dr. Alex Chen, Director of Interventional Pulmonology, Assistant Professor of Medicine and Surgery, Divisions of Pulmonary and Critical Care Medicine and Cardiothoracic Surgery, Washington University in St. Louis, MO. “The scope’s rotation capabilities also allow for more comfortable hand positions during procedures, reducing hand fatigue and potentially improving procedural ergonomics.”</p>
<p>In addition to the BF-P190 bronchoscope, Olympus offers a comprehensive peripheral bronchoscopy solution, including the radial endobronchial ultrasound (EBUS) probes (unique to Olympus), ultrasound processors, Guide Sheath Kit, TBNA needles, biopsy forceps and cytology brushes for extended reach beyond the tip of the scope.</p>
<p><strong>BF-XP190 Advances Visualization in Small Anatomy Bronchoscopy</strong><br />
Flexible bronchoscopy is widely used in the diagnosis of respiratory pathologies in people of all ages. Biopsies, bronchoscopic cytology and foreign body removal present common challenges that are often addressed using bronchoscopy.</p>
<p>The BF-XP190 provides a new evolution of better imaging in an ultra-slim bronchoscope. A revolutionary mini CCD provides unsurpassed image quality compared to other ultra-slim bronchoscopes, and close-up observation of bronchial surfaces can be easily accessed with 1.2 x and 1.5 x electronic magnification.</p>
<p>With an outside diameter of 3.1 mm — nearly 1 mm smaller than its nearest competitor — and a 1.2 mm working channel, the BF-XP190 is the industry’s slimmest true videoscope, making it the scope of choice for small anatomy bronchoscopy.</p>
<p><strong>BF-190 Bronchoscopes Powered by EVIS EXERA III Universal Platform</strong><br />
The BF-P190 and BF-XP190 bronchoscopes are designed to advance maneuverability, visualization and versatility. Key features include:</p>
<ul><li>Rotary Function: Insertion tube rotation of up to 120° left and right effectively reduces hand torque by 82%,<a href="#_edn3" name="_ednref3" title="" id="_ednref3">[iii]</a> expands access in the periphery of the lungs, and supports easier insertion and positioning of endoscopic devices.</li>
<li>210° Tip Angulation: The wide angulation range can be maintained even when an endoscopic device is inserted, making it easier to access difficult-to-reach peripheral areas of the lungs.</li>
<li>SDTV Imaging: SDTV offers the highest quality imaging available in scopes of similar size. These scopes, in tandem with the EVIS EXERA III platform, offer the first true video system on the market for peripheral and small anatomy bronchoscopy.</li>
<li>EVIS EXERA III Universal Platform: This powerful imaging system helps facilitate more accurate diagnosis and treatment and also simplifies set up and reprocessing. The system works seamlessly across specialties to provide easier data management and cost efficiencies.</li>
</ul><p>“The BF-P190 and BF-XP190 bronchoscopes offer improved diagnostic capabilities and procedural efficiency using a minimally invasive approach,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “These new technologies will help our customers meet the triple aim of Affordable Care by improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p>The BF-P190 and BF-XP190 bronchoscopes will be showcased at the American Thoracic Society (ATS) 2014 International Conference to be held on May 16-21 in San Diego, CA. Physicians are invited to visit Booth #4907 to further explore the benefits of these newest additions to the revolutionary BF-190 bronchoscope series.</p>
<p>For more information or to evaluate any of the BF-190 bronchoscopes, please contact your Olympus representative or call 800-848-9024.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey<br />
Olympus Corporation of the Americas<br />
484-896-5120<br /><a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<hr align="center" size="1" /><p><a href="#_ednref1" name="_edn1" title="" id="_edn1">[i]</a> Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</p>
<p><a href="#_ednref2" name="_edn2" title="" id="_edn2">[ii]</a> Geraghty P, et al. “CT-guided Transthoracic Needle Aspiration Biopsy of Pulmonary Nodules: Needle Size and Pneumothorax Rate.” <em>Radiology </em>2003; 229(2):475-481.</p>
<p><a href="#_ednref3" name="_edn3" title="" id="_edn3">[iii]</a> When compared to standard Olympus bronchoscopes. Data on file.</p>
</div></div></div>Wed, 07 May 2014 16:05:00 +0000joshua.boltz@olympus.com2548 at https://medical.olympuscanada.comOlympus Launches New, Minimally Invasive Innovation for Capsule Endoscopy Procedureshttps://medical.olympuscanada.com/articles/olympus-launches-new-minimally-invasive-innovation-capsule-endoscopy-procedures
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>ENDOCAPSULE 10 Delivers Outstanding Visualization, Improved Efficiency and<br />
Enhanced Features for Noninvasive Observation of the Small Intestine</em></p>
<p><strong>CENTER VALLEY, Pa., May 5, 2014</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation ENDOCAPSULE 10 System for small bowel capsule endoscopy procedures.</p>
<p>Today, thousands of Americans are plagued with disorders of the small bowel, including chronic constipation or diarrhea, bleeding, infections, cancers, ulcers, obstructions, celiac and Crohn’s disease, and irritable bowel syndrome among others. Advances in endoscopic technology — including capsule endoscopy — have helped physicians better detect and treat small bowel disorders at earlier stages. According to Truven Health, 137,850 outpatient capsule endoscopies were performed in the United States in 2012.<a href="#_edn1" name="_ednref1" title="" id="_ednref1"><sup><sup>[i]</sup></sup></a></p>
<p>“The new ENDOCAPSULE 10 System offers advanced, minimally invasive technology designed to improve diagnostic capabilities, procedural efficiency and patient comfort,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “The system can help facilities fulfill the requirements of healthcare reform aimed at improving quality of care, decreasing costs and enhancing patient satisfaction.”</p>
<p><strong>Outstanding Visualization</strong><br />
The ENDOCAPSULE 10 System features advanced Olympus lens technology and sensitive, high-resolution image sensor technology to provide clear and vivid imaging results for fine observation of a variety of abnormalities in the small bowel. The capsule’s 160° field of view sees 10% more mucosa than the other capsule endoscopy products featuring a 145° field of view. In addition, the new system offers a long 12-hour battery life to maximize the amount of images taken and improve exam completion rates.</p>
<p><strong>Improved Efficiency</strong><br />
Intelligent software built into the system simplifies the reading and analysis of the captured imagery, automatically detects images that require closer inspection and indicates where each thumbnail image was captured to determine location of any detected abnormalities. A 3D tracking function allows the system to display the capsule position inside the body to check its progress as it moves through the intestine.</p>
<p><strong>Enhanced User Features</strong><br />
In addition to improvements in the imaging and software technologies, the system also features improvements that increase ease of use for clinicians and patients. The recorder unit is now lighter, more compact and more comfortable to wear with an improved harness and an antenna that can be worn over clothes rather than applied directly to the skin. The recorder allows quick initialization by the clinician and allows image to be viewed in real time or via download later to the system’s workstation.</p>
<p>The ENDOSCAPSULE 10 System will be showcased at Digestive Disease Week (DDW) 2014 to be held May 3-6 in Chicago, IL. Physicians are invited to visit Booth #2118 to see the latest features and improvements in capsule endoscopy.</p>
<p>For more information about the ENDOCAPSULE 10 System, please contact your Olympus sales representative by calling 866-888-1950.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey<br />
Olympus Corporation of the Americas<br />
484-896-5120<br /><a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<hr align="left" size="1" width="33%" /><p><a href="#_ednref1" name="_edn1" title="" id="_edn1">[i]</a> Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</p>
</div></div></div>Mon, 05 May 2014 13:26:15 +0000joshua.boltz@olympus.com2546 at https://medical.olympuscanada.comNew Olympus EU-ME2 Ultrasound Processor Delivers Versatile, Cost-Effective Resource for Sharing Across Specialtieshttps://medical.olympuscanada.com/articles/new-olympus-eu-me2-ultrasound-processor-delivers-versatile-cost-effective-resource-sharing
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Ultrasound Imaging Platform Supports Better Detection and Characterization of<br />
Lesions in the Gastrointestinal Tract and Airways</em></p>
<p><strong>CENTER VALLEY, Pa., May 2, 2014</strong> – Olympus, a precision technology leader in designing and delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today the launch of the next-generation EU-ME2 Ultrasound Processor, which can integrate endoscopic and endobronchial ultrasound (EUS/EBUS) on a single workstation. The EU-ME2 provides better performance than current solutions and realizes cost savings through cross-departmental functionality for the GI and pulmonary markets.</p>
<p><strong>GI Market/EUS</strong><br />
Olympus is a pioneer of <a href="http://www.olympusamerica.com/presspass/press_pass_cut/documents/EUSBackgrounder_711.pdf">endoscopic ultrasound (EUS)</a>, which combines ultrasound technology with endoscopy to better visualize the tissues of the digestive tract and adjacent anatomical structures inside the human body. With EUS, the transducer is endoscopically inserted into the body via the digestive tract, putting it closer to the area of interest to obtain higher resolution images.</p>
<p>For EUS, the EU-ME2 provides outstanding image quality, comparable to a large radiology processor, in a compact model. It is designed to meet the needs of gastroenterologists performing a wide range of EUS procedures. New and enhanced features improve visualization and assist in diagnostic, therapeutic and interventional procedures for cancers and diseases of the GI track and surrounding organs, such as the pancreas, bile duct, liver, spleen and gallbladder.</p>
<p>“EU-ME2 is a major development in the field of pancreatic-biliary endoscopy, as EUS is increasingly being used for accessing the bile duct following a failed cannulation at ERCP,” said Dr. Shyam Varadarajulu, Medical Director of the Center for Interventional Endoscopy (CIE) and Professor of Medicine at the University of Central Florida. “The technology is advanced, compact, versatile and packed with “high-end” features; it seamlessly integrates diagnostic and therapeutic capabilities that will elevate care to the next higher level for years to come.”</p>
<p>According to the American Cancer Society, there are more than 125,000 newly diagnosed cases of gastrointestinal-related cancers each year in the United States with more than 91,000 deaths from these diseases in 2013. In addition, Truven Health estimates that the total number of EUS outpatient procedures will grow 15% from 2011 to 2016 and reach 235,000 procedures.<a href="#_edn1" name="_ednref1" title="" id="_ednref1">[i]</a></p>
<p><strong>Pulmonary Market/EBUS</strong><br />
The system also offers full support for <a href="https://medical.olympusamerica.com/procedure/ebus">endobronchial ultrasound (EBUS)</a> procedures. EBUS allows visualization of the airways and adjacent structures. Along with its predecessor, Olympus’ EU-ME2 is the only platform that offers both linear and radial EBUS capabilities in one ultrasound processor for enhanced procedural and cost efficiencies.</p>
<p>New ACCP Lung Cancer Guidelines recommend EBUS-TBNA (transbronchial needle aspiration) over surgical staging for mediastinal staging of lung cancer as a best first test. EBUS-TBNA offers a nonsurgical solution using real-time ultrasound-guided tissue sampling. In addition, radial EBUS is recommended as an adjunct imaging modality for patients who have a peripheral lung nodule and for whom a tissue diagnosis is required due to uncertainty of diagnosis or poor surgical candidacy. EBUS-TBNA and radial EBUS support procedures for early, minimally invasive diagnosis and lung cancer staging. Both methods are beneficial for patient care and support cost-sensitive goals since each procedure can be performed on an outpatient basis instead of requiring a more complex procedure or surgery.</p>
<p>According to Lung Cancer Alliance data, lung cancer is the leading cause of all cancer-related deaths in the United States among every ethnic group, taking more lives than breast, prostate and colon cancers combined. Only 15% of lung cancer is diagnosed at its earliest and most curable stage, and more than 55% of cases are diagnosed after the cancer has metastasized.</p>
<p><strong>EU-ME2 Benefits</strong><br />
The versatile EU-ME2 is forward and backward compatible with a wide range of Olympus EUS and EBUS scopes as well as ultrasound miniature probes. Since the processor is appropriate for gastroenterology, pulmonary and thoracic surgery departments, it offers healthcare facilities with a cost-effective resource that can be shared across specialties.</p>
<p>“As healthcare facilities look for ways to improve patient satisfaction while reducing care delivery costs, we are pleased to be able to offer our customers a versatile, state-of-the-art ultrasound platform for GI and pulmonary applications,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “The EU-ME2 enables physicians to realize clinical efficacy through premier imaging. It also helps healthcare facilities achieve efficient asset management to realize significant cost savings through lower cost of ownership.”</p>
<p>With its high-resolution imaging and an image display that promotes clear visualization, the EU-ME2 brings superb clarity to EUS and EBUS procedures, supporting better detection and characterization of lesions in the gastrointestinal tract and airways. This next-generation processor further expands the boundaries of endosonography with advanced features such as:</p>
<ul><li>Improved B-mode for more accurate identification of tumors and tissue properties and boundaries</li>
<li>High Resolution Flow (H-Flow) mode to image small vessels around the tip of the endoscope for more precise anatomical identification</li>
<li>Pulse Wave Doppler (PWD) mode to measure blood flow velocity in a specific location to help identify the target area of interest</li>
<li>Elastography (ELST)<a href="#_edn2" name="_ednref2" title="" id="_ednref2">[ii]</a> mode to map tissue elasticity, which may help indicate disease and highlight areas to biopsy</li>
<li>Tissue Harmonic Echo (THE)<sup>ii</sup> mode for improved resolution, improved signal-to-noise ratio, and reduced imaging artifacts</li>
</ul><p>The EU-ME2 Ultrasound Processor will be showcased at Digestive Disease Week 2014 to be held on May 3-6 in Chicago, IL. Physicians are invited to visit Booth #2118 to further explore the benefits of this versatile ultrasound imaging platform.</p>
<p>For more information or to evaluate the EU-ME2 Ultrasound Processor, please contact your Olympus representative or call 800-848-9024.</p>
<p>The EU-ME2 joins a comprehensive lineup of Olympus ultrasound processors, including the <a href="http://medical.olympusamerica.com/products/premier-ultrasound-platform-prosound-f75">ProSound F75</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey<br />
Olympus Corporation of the Americas<br />
484-896-5120<br /><a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<hr align="left" size="1" width="33%" /><p style="margin-left:9.0pt;"><a href="#_ednref1" name="_edn1" title="" id="_edn1">[i]</a> Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</p>
<p style="margin-left:9.0pt;"><a href="#_ednref2" name="_edn2" title="" id="_edn2">[ii]</a> Only available in the Premier Plus version of the EU-ME2.</p>
</div></div></div>Thu, 01 May 2014 13:33:37 +0000joshua.boltz@olympus.com2507 at https://medical.olympuscanada.comOlympus Reduces Risk of Cross-Contamination and Costly Repairs with ALT-Pro Automatic Leak Tester for Endoscope Reprocessinghttps://medical.olympuscanada.com/articles/olympus-reduces-risk-cross-contamination-and-costly-repairs-alt-pro-automatic-leak-tester
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Fastest, Most Compact System Frees Up Staff Time and Counter Space,<br />
and Can Prevent Human Error</em></p>
<p><strong>CENTER VALLEY, Pa., April 24, 2014</strong> – Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions for Medical and Surgical procedures, among other core businesses, announced today the launch of the fastest, most compact Automated Endoscope Leak Tester on the market, ALT-Pro – a system that prevents human error while enhancing efficiency in endoscope reprocessing.</p>
<p>“We’re pleased to introduce what may well be the gold standard in endoscope leak testing,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “The ALT-Pro’s innovative dry leak testing technology takes the guesswork out of endoscope leak testing by removing the human elements that lead to human error. With endoscopes serving as the channel for an expanding range of high-tech surgical and diagnostic devices, the technology used to protect them should also continue to advance. The ALT-Pro will be a welcome addition to reprocessing departments.”</p>
<p>Conventional endoscope leak testing includes pressurizing an endoscope with an air pumping device while submerging the endoscope in water, angulating the scope’s distal tip and manually flexing and manipulating the entire exterior area of the endoscope while observing the water for air bubbles. Submersion leak-testing methods rely heavily upon acute observation and proper technician training to accurately recognize early-stage endoscope leaks. By finding endoscope leaks sooner, the potential for endoscope cross-contamination and costly endoscope repairs can be reduced.</p>
<p>The ALT-Pro’s dry leak testing technology is fully computerized, creating a highly repeatable endoscope leak testing process for all skill levels. Simply attach up to two endoscopes, start the leak test process and walk away until the leak test is finished. A built-in Radio Frequency Identification (RFID) reader promotes accurate record keeping and enables precise early-stage leak detection by inflating the endoscope based on its specific model. Additionally, the ALT-Pro’s small footprint and optional wall mount reduce countertop clutter.</p>
<p>According to the American Society for Gastrointestinal Endoscopy, the risk of infection from scope contamination is <a href="http://www.asge.org/press/press.aspx?id=6858">one in 10 million</a> procedures; however, the damage to one person’s health should not be underestimated, nor should the detriment a preventable infection can cause to one health facility’s brand.</p>
<p><strong><em>ALT-Pro Benefits</em></strong></p>
<p>The ALT-Pro dry endoscope leak test eliminates the need for endoscope submersion, air bubble observation and distal tip angulation. Other features include:</p>
<ul><li>Simple 3-step process: Scan (via RFID), Connect and Start</li>
<li>Easy-to-read LCD display includes work flow instructions, test results and settings</li>
<li>Choice between automated (dry) and conventional submersion leak testing modes to help meet your needs</li>
<li>Self check on startup that ensures the unit is operating properly</li>
<li>Electronic export feature that allows for records export to a PC for backup or analysis</li>
<li>12-month warranty that protects investment</li>
</ul><p>The ALT-Pro helps address key requirements of Healthcare Reform and the Affordable Care Act, including:</p>
<ul><li><strong>Increased Quality of Care</strong> – The ALT-Pro's fully automated dry leak<br />
test process reduces human error by removing the human elements of manual endoscope leak testing methods.</li>
<li><strong>Decreased Costs – </strong>The early detection of endoscope leaks may reduce<br />
the severity of damage to the endoscopes’ internal components, reducing<br />
expensive endoscope repair costs.</li>
<li><strong>Enhanced Patient Satisfaction</strong> – The accurate detection of endoscope<br />
leaks reduces the potential for patient infection through endoscope cross-<br />
contamination.</li>
</ul><p>The ALT-Pro will be showcased at the 2014 SGNA Annual Course to be held on May 2-6 in Nashville, Tenn. Healthcare providers are invited to visit Booth #400 to further explore the benefits of this important new leak testing technology. The ALT-Pro will also be showcased at APIC 2014 in Anaheim, Calif., June 7-9, 2014.</p>
<p>For more information or to evaluate the ALT-Pro, please contact your Olympus representative at 800-848-9024 or visit <a href="http://medical.olympusamerica.com/customer-resources/cleaning-disinfection-sterilization/reprocessing-products/alt-pro">http://medical.olympusamerica.com/customer-resources/cleaning-disinfection-sterilization/reprocessing-products/alt-pro</a>. </p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey<br />
Olympus Corporation of the Americas<br />
484-896-5120<br /><a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Wed, 23 Apr 2014 14:40:56 +0000joshua.boltz@olympus.com2506 at https://medical.olympuscanada.comTwo Olympus Innovations Named Finalists for American Technology Awardhttps://medical.olympuscanada.com/articles/two-olympus-innovations-named-finalists-american-technology-award
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>TechAmerica Foundation </em><em>“Best Of” Award Recognizes ENDOEYE FLEX 3D and<br />
THUNDERBEAT in Health and Medical Technologies Category</em></p>
<p><strong>CENTER VALLEY, Pa., April 17, 2014 – </strong>Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT<strong>. </strong></p>
<p>The ATA awards, presented by the TechAmerica Foundation, represent outstanding achievement and are the only “Best of” national award in the technology industry. The two Olympus surgical products will be recognized in Washington, D.C. on May 20, 2014 at 1776, D.C.’s premier tech startup, when the ATA winners will be selected.</p>
<p>Both of the Olympus products represent world’s only innovations in the surgical market:</p>
<ul><li><a href="http://medical.olympusamerica.com/products/endoeye-flex-3d"><strong>ENDOEYE FLEX 3D</strong></a> is the world’s only articulating HD 3D laparoscopic surgical imaging system, which improves the speed, accuracy and precision of surgical procedures based on testing using a simulated surgical model. This is accomplished by restoring a surgeon’s natural 3D vision and depth perception during laparoscopic procedures. The technology is available as a module that can be easily added to an existing Olympus EVIS EXERA III universal imaging system. <br />
</li>
<li><a href="http://medical.olympusamerica.com/products/thunderbeat"><strong>THUNDERBEAT</strong></a> is the world’s only platform that combines advanced bipolar and ultrasonic energies into a single multifunctional instrument. This allows surgeons to simultaneously seal and cut vessels, minimizing instrument exchanges and reducing procedure time. Additionally, it boasts the fastest cutting speed and provides the highest grasping force at the tip when compared to other leading energy instruments.</li>
</ul><p>“Each year the quality of the nominations we get for the American Technology Awards improves. The amazing innovations and advancement in technology that each of the finalists represent is a true testament to the quality of our industry in this country,” said Shawn Osborne, Chairman of the TechAmerica Foundation. “We congratulate Olympus on being a finalist for this prestigious award.”</p>
<p>“It’s exciting that our hard work to serve the needs of surgeons and their patients can also translate into technology industry recognition of our innovations,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “Both ENDOEYE FLEX 3D and THUNDERBEAT will help hospitals and healthcare providers deliver world-class care to their patients through early, minimally invasive diagnosis and treatment of diseases and other conditions.”</p>
<p>Olympus is a pioneer of minimally invasive surgery (laparoscopy), a modern technique in which an operation in the abdomen is performed through small incisions as compared to larger incisions needed in traditional surgical procedures. This surgical approach addresses the key requirements of Healthcare Reform:</p>
<ul><li><strong>Increased Quality of Care</strong> – Minimally invasive surgery provides better clinical outcomes than traditional “open” surgery.</li>
<li><strong>Decreased Costs</strong> – Numerous industry and clinical studies have demonstrated that minimally invasive surgery provides significant cost savings when compared to a robotic surgical approach.*</li>
<li><strong>Enhanced Patient Satisfaction</strong> – Minimally invasive surgery provides less scarring, shorter hospital stays and faster recovery than traditional “open” surgery.</li>
</ul><p>More information about THUNDERBEAT, ENDOEYE FLEX 3D and other Olympus medical and surgical products is available at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.<br /><em>*Data on file.</em></p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>About TechAmerica Foundation</strong><br />
TechAmerica Foundation educates industry executives, policy makers and opinion leaders on the promise of technological innovation to advance prosperity, security and the general welfare. Launched in 1981, the Foundation is a 501(c) (3) non-profit, non-partisan affiliate of TechAmerica, which is the leading voice and resource for the U.S. technology industry. The Foundation disseminates award-winning industry, policy and market research covering topics such as U.S. competitiveness in a global economy, innovation in government, and other areas of national interest. It also organizes conferences and seminars to explore pertinent issues with government and industry representatives and to share the Foundation’s findings. Learn more about TechAmerica Foundation at <a href="http://www.techamericafoundation.org">www.techamericafoundation.org</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a><br />
Stephanie Craig, TechAmerica Foundation, 202-682-4443, <a href="mailto:Stephanie.craig@techamericafoundation.org">Stephanie.craig@techamericafoundation.org</a></p>
</div></div></div>Wed, 16 Apr 2014 15:19:49 +0000joshua.boltz@olympus.com2505 at https://medical.olympuscanada.comOlympus Launches Awareness Initiatives in Support of National Colorectal Cancer Awareness Monthhttps://medical.olympuscanada.com/articles/olympus-launches-awareness-initiatives-support-national-colorectal-cancer-awareness-month
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Leader in GI Endoscopy Promotes Screening for Colorectal Cancer </em><br /><em>that Affects Millions of Americans Nationwide</em></p>
<p><strong>CENTER VALLEY, Pa., March 10, 2014</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today its efforts in promoting <a href="http://www.CRCAwareness.com" target="_blank">National Colorectal Cancer (CRC) Awareness Month</a>. March 2014 marks the 15<sup>th</sup> annual National CRC Awareness Month, observed annually to educate the community on this prevalent disease and promote awareness for cancer screening, prevention and testing. Primary among the initiatives is its partnership with Dr. Douglas Rex, a nationally-recognized colonoscopy expert and pioneer.</p>
<p>Colorectal cancer continues to be a major health issue: Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer-related deaths in the U.S. (Centers for Disease Control). Nearly 143,000 Americans will be diagnosed with colon cancer this year, and an estimated 51,000 people will die from it (American Cancer Society). The cost to care for colorectal cancer is estimated to be more than $50,000 in the first year of diagnosis alone (National Cancer Institute).</p>
<p>Colorectal cancer is preventable with early and regular screening. The U.S. Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer by one of several tests, including a colonoscopy, beginning at age 50 years and continuing until age 75 years. Still only about 60 percent of American adults aged 50 and older get screened for colorectal cancer (American College of Physicians).</p>
<p>To improve the percentage of patients who are recommended for screening, actually seeking it out, many organizations promote awareness about the disease’s dangers and preventability. Among Olympus’ activities during this important health awareness month are:</p>
<ul><li>Partnering with Professor Douglas Rex, M.D. on a satellite TV and radio media tour to provide interviews nationwide about the benefits of screening for colorectal cancer. In addition, Dr. Rex will discuss the importance of colonoscopy in early detection and treatment of colorectal cancer.</li>
<li>Sponsoring a Colon Cancer Coalition “Get Your Rear in Gear” 4-mile run to raise cancer awareness and positively impact screening rates, Sunday March 23<sup>rd</sup> in Philadelphia. Registration information is available at: <a href="http://getyourrearingear.com/events/list/2014/philadelphia-pa-2014/" target="_blank">http://getyourrearingear.com/events/list/2014/philadelphia-pa-2014/</a></li>
<li>Hosting a CRC educational event at Olympus with Dr. Steven Lichtenstein, Director of the Division of Gastroenterology at Philadelphia’s Mercy Fitzgerald Hospital, scheduled for March 21st at the Olympus’ Center Valley headquarters for the Americas. Dr. Lichtenstein will educate participants about the disease and share compelling patient stories of colon cancer survival.</li>
<li>Motivating employees to become educators about the importance of colorectal screening within the community. For example, Olympus is empowering employees to discuss CRC screening with friends and family through a variety of educational materials such as palm cards and magnets.</li>
</ul><p>“Colonoscopy is considered the gold standard of screening for early detection and prevention of colorectal cancer,” said Dr. Douglas Rex, Distinguished Professor of Medicine, Indiana University, MD, FACP, AGAF, FACG, FASGE. “A colonoscopy can find precancerous polyps so they can be removed before they turn into cancer. I’m pleased to help Olympus spread the word about prevention and intervention.”</p>
<p>As one of the top colonoscopy experts in the world, Professor Douglas Rex organized the first trial of using colonoscopy to screen average-risk individuals in 1987. In this trial, nearly 800 asymptomatic health professionals and their spouses underwent screening colonoscopy. This trial, along with the dozens of other investigations Rex has produced over the past two decades, helped transform colonoscopy from an uncommon and potentially dangerous procedure to the most effective screening test against any form of internal cancer and one of the most widely performed medical procedures in the United States.</p>
<p>Olympus is the leading manufacturer of medical devices used to peer inside the human body to detect, diagnose and treat gastrointestinal diseases such as colorectal cancer. Olympus pioneered the development of endoscopic technology more than 50 years ago and remains a global leader today, helping to improve the lives of millions who have been diagnosed or screened for colorectal cancer. More information about Colorectal Cancer Awareness Month is available at <a href="http://www.CRCawareness.com">www.CRCawareness.com</a>.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures and innovative diagnostic and therapeutic endoscopy, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com" target="_blank">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Fri, 07 Mar 2014 14:30:07 +0000joshua.boltz@olympus.com2494 at https://medical.olympuscanada.comOlympus Ranked Among Top 10 Innovators in Medical Devices and Services Industryhttps://medical.olympuscanada.com/articles/olympus-ranked-among-top-10-innovators-medical-devices-and-services-industry
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Company Secures Top 10 Position for the 12<sup>th</sup> Consecutive Scorecard</em></p>
<p><strong>CENTER VALLEY, Pa., November 13, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, was ranked 8<sup>th</sup> among the top 10 innovators in the medical devices and services industry by The Patent Board™, the official patent ratings partner of <em>The Wall Street Journal</em>.</p>
<p>The Patent Board™ tracks and analyzes innovation, movement, and the business impact of U.S. patent assets across 17 industries on a global basis. <em>The Wall Street Journal Online</em> (WSJ.com) has published The Patent Board Scoreboard since 2007, offering its readers insights into portfolios as measurable financial assets and drivers of market value. Olympus reached the top 10 position for Medical Devices &amp; Services in the February 2010 and has remained there for 12 consecutive scorecards.</p>
<p>“It is an honor to be recognized by The Patent Board as a leading innovator in the medical device industry,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “This ranking validates our innovative medical and surgical solutions and reinforces our focus on helping to meet the triple aim of Affordable Care through improved clinical outcomes, reduced overall costs and enhanced quality of life for patients.”</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures and innovative diagnostic and therapeutic endoscopy, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Tue, 12 Nov 2013 19:14:35 +0000joshua.boltz@olympus.com2473 at https://medical.olympuscanada.comOlympus Introduces World’s Only Forward-Viewing Curvilinear Ultrasound Gastrovideoscopehttps://medical.olympuscanada.com/articles/olympus-introduces-world%E2%80%99s-only-forward-viewing-curvilinear-ultrasound-gastrovideoscope
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>TGF-UC180J Provides the Potential for New Opportunities<br />
in EUS-Guided Treatment of Diseases in the GI Tract</em></p>
<p><strong><img alt="" src="/sites/default/files/pictures/HI_1_A-Comp.jpg" style="width: 266px; height: 190px; border-width: 0px; border-style: solid; margin: 5px; float: right;" />CENTER VALLEY, Pa., October 9, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in the medical and surgical field, among other core businesses, announced today the launch of its 510(k) cleared and world’s only forward-viewing curvilinear ultrasound gastrovideoscope.</p>
<p>The advanced design of Olympus’ new EUS scope with forward-viewing optics makes it an ideal interventional tool. The design of the scope is significant because it provides a reduced distal tip length compared to its oblique-viewing counterparts. The combination of a shorter tip with wider angulation capabilities (180 degrees up) delivers enhanced maneuverability and handling. In addition, the scope’s straight channel enables therapeutic devices to be delivered directly (or head on) to the target site, potentially providing easier access to regions of interest.</p>
<p>The scope’s enhanced maneuverability and handling offers the potential to improve visualization of fundus diseases, which can be challenging to view and diagnose. In addition, an auxiliary water jet potentially provides better acoustic coupling as well as savings in accessory costs by eliminating the need for a balloon.</p>
<p>"The forward-viewing therapeutic echoendoscope is a major advance for interventional endoscopy,” said Dr. Kenneth Binmoeller, Medical Director of the Interventional Endoscopy Service (IES) at California Pacific Medical Center. “It is the first true ‘hybrid’ ultrasound endoscope, enabling both ultrasound and endoscopy-guided interventions with the same instrument. This will facilitate existing EUS-guided therapies, such as pseudocyst drainage, as well as enable new EUS-guided treatments."</p>
<p>The TGF-UC180J is powered by the new, next-generation ProSound F75 Ultrasound Imaging Platform, developed in partnership by Hitachi Aloka Medical, Ltd., which aids in more accurate diagnosis of diseases and cancers of the GI track and surrounding organs. The scope is also backward compatible with prior generation processors, including the Olympus EU-ME1 and Hitachi Aloka SSD-α10.</p>
<p>“We are pleased to introduce this newest advance in EUS technology,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “The TGF-UC180J has the potential to pave the way for new EUS-guided treatments and assist healthcare facilities in their efforts to meet the triple aim of Affordable Care through advanced diagnostic and therapeutic capabilities, clinical and cost efficiencies, and less invasive interventions for treatment of diseases and cancers in the GI tract.”</p>
<p>Olympus is a pioneer of <a href="http://www.olympusamerica.com/presspass/press_pass_cut/documents/EUSBackgrounder_711.pdf">endoscopic ultrasound</a> (EUS), which combines ultrasound technology with endoscopy to better visualize the tissues of the digestive tract and adjacent anatomical structures inside the human body. Conventional ultrasound is performed by placing a transducer against the skin to produce images of internal organs. With EUS, the transducer is endoscopically inserted into the body via the digestive tract, putting it closer to the region of interest to obtain higher resolution images.</p>
<p>The demand for minimally invasive procedures continues to grow with the introduction of more advanced technologies. Over 250,000 EUS outpatient procedures were performed in the United States in 2011 (Truven Health<a href="#_edn1" title="">[i]</a>) with a 6% compound annual growth rate for the next 5 years (The Advisory Board Company).</p>
<p>The advanced design of the TGF-UC180J scope can help healthcare providers address the key requirements of healthcare reform, including:</p>
<ul><li><strong>Increased Quality of Care</strong> – EUS drives optimal patient outcomes through easy identification and more accurate staging of diseases and cancers in the GI tract.</li>
<li><strong>Decreased Costs</strong> – Interventional procedures can be performed in the GI suite which saves OR time. In addition, the forward-viewing scope does not require a balloon, reducing accessory expenditures.</li>
<li><strong>Enhanced Patient Satisfaction</strong> – EUS offers patients a less invasive treatment compared to surgical interventions, and procedure times may be shorter.</li>
</ul><p>The TGF-UC180J ultrasound gastrovideoscope will be showcased on October 13-15, 2013, at the ACG 2013 Annual Scientific Meeting, which will be held in San Diego, CA. Physicians are invited to visit booth #1027 to further explore the benefits of the new forward-viewing scope technology.</p>
<p>For more information or to evaluate the TGF-UC180J ultrasound gastrovideoscope, please contact your Olympus representative or call 800-848-9024.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />
Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<hr align="left" size="1" width="33%" /><p><a name="_edn1" title="" id="_edn1">[i]</a> Data for use in this study were supplied by Truven Health Analytics Inc., Ann Arbor, Michigan (“Truven Health”). Any analysis, interpretation or conclusion based on these data is solely that of the authors and Truven Health disclaims responsibility for any such analysis, interpretation or conclusion.</p>
</div></div></div>Wed, 09 Oct 2013 13:14:43 +0000joshua.boltz@olympus.com2461 at https://medical.olympuscanada.comOlympus Launches DIEGO® ELITE Multidebrider® Platform for Sinus, Turbinate, Tonsil, Adenoid and Laryngeal Surgerieshttps://medical.olympuscanada.com/articles/olympus-launches-diego%C2%AE-elite-multidebrider%C2%AE-platform-sinus-turbinate-tonsil-adenoid-and
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>New technology delivers optimal tissue dissection with built-in hemostasis<br />
and improves speed of sinus surgeries by 12%</em></p>
<p><a class="fancybox" href="/sites/default/files/pictures/diego.jpg"><img alt="" src="/sites/default/files/pictures/diego.jpg" style="width: 350px; height: 243px; border-width: 0px; border-style: solid; margin: 5px; float: right;" /></a><strong>CENTER VALLEY, Pa., September 26, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in the medical and surgical field, among other core businesses, announced today that it has launched a new platform for use in minimally invasive sinus surgery – the Olympus DIEGO® ELITE Multidebrider®. The device will be showcased at the <a href="http://www.entannualmeeting.org/13/">American Association of Otolaryngology - Head &amp; Neck Society (AAO-HNSF) Annual Meeting</a>, September 29 to October 2, in Vancouver, BC. </p>
<p>Approximately 1,333,000 sinus surgeries to eliminate blockages causing sinus pain and impaired breathing are performed in the U.S. each year (Truven Health OPV 2011). These surgeries often require a wide variety of cutting blades and tools for each procedure. The Olympus DIEGO ELITE Multidebrider is the world’s only ENT system to offer both monopolar and bipolar energy blades for hemostasis – as well as traditional standard shaver blades – providing specialists with a full array of surgery options using just one device. Applications for the Olympus DIEGO ELITE include sinus surgery, polypectomy, tonsillectomy, adenoidectomy, inferior turbinate reduction, and laryngeal applications.</p>
<p>Procedures powered by the Olympus DIEGO ELITE Multidebrider offer significantly shorter surgery times compared to those performed using standard blades. Devices with bipolar energy have been shown to reduce bleeding and expedite operating times by as much as 12%, as the average procedure time during the study dropped from 101.4 minutes to 88.9 minutes.<a href="#_ftn1" name="_ftnref1" title="" id="_ftnref1">[1]</a> In addition, compared to its predecessor, the DIEGO ELITE offers improved coagulation performance and further expedites procedures, delivering 27%<a href="#_ftn2" name="_ftnref2" title="" id="_ftnref2">[2]</a> faster tissue removal than previous models. </p>
<p>“Never have I had so many options with one device,” said Alexander Chiu, MD, Professor and Interim Chair, Department of Surgery and Chief of the Division of Otolaryngology-Head and Neck Surgery at the University of Arizona and member of the DIEGO ELITE evaluation team. “The Olympus DIEGO ELITE Multidebrider is ideal for all types of sinus and endoscopic skull base surgery. Its versatility enables more efficient and safer procedures, reducing the need for instrument exchanges and allowing me to get to the source of bleeding instantly.” Dr. Chiu will share his perspective and experience with the Olympus DIEGO ELITE Multidebrider during presentations at the AAO meeting.</p>
<p>The Olympus DIEGO ELITE Multidebrider further expedites surgeries and procedural efficiency with features such as a toggle stop to quickly open or close the blade window, dedicated suction along with a convenient bulb for easy de-clogging during the procedure, choice of ergonomic hand pieces suited to physician preference, and a blade ID feature that ensures every time a new blade is plugged in, the device will default to the recommended setting for that blade.</p>
<p>“With reduced procedure times and the potential to decrease pain and shorten healing periods, innovations like the Olympus DIEGO ELITE Multidebrider allow us to further our commitment to providing premier care, while supporting our customers achieve the clinical efficacy and cost effectiveness required under Accountable Care,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas.</p>
<p>Olympus plays a major role in the sinus surgery market offering a complete range of products, including HD imaging systems, wide angled sinuscopes, precision hand instruments and nasal packing. The Olympus DIEGO ELITE Multidebrider addresses the following key requirements of Healthcare Reform:</p>
<ul><li><strong>Increased Quality of Care</strong>: An additional option to control bleeding at the source with fewer instrument exchanges ensures that patients receive the best quality of care.</li>
<li><strong>Decreased Costs</strong>: A 12% reduction in procedure time leads to reduced OR time and operating costs.<a href="#_ftn3" name="_ftnref3" title="" id="_ftnref3">1</a></li>
<li><strong>Enhanced Patient Satisfaction</strong>: Bipolar SMR blades control bleeding better than standard blades<a href="#_ftn4" name="_ftnref4" title="" id="_ftnref4">1</a> <a href="#_ftn5" name="_ftnref5" title="" id="_ftnref5">[3]</a>.</li>
</ul><p>“The Olympus DIEGO ELITE Multidebrider, manufactured in the U.S., offers an unrivaled level of surgeon choice, paired with ease of use,” said Georg Schloer, President of Olympus Surgical Technologies America, Olympus’ American medical product development and manufacturing unit. “The system was designed in collaboration with a team of customers because it was important to capture not only the requirements of surgeons but also of staff members involved in device preparation prior to surgery.”</p>
<p>The Olympus DIEGO ELITE Multidebrider will be showcased at the <a href="http://www.entannualmeeting.org/13/">American Association of Otolaryngology - Head &amp; Neck Society (AAO-HNSF) Annual Meeting</a>, September 29 to October 2, in Vancouver, B.C. Surgeons are invited to visit booth #1604 to experience the benefits of the Olympus DIEGO ELITE Multidebrider firsthand.</p>
<p>For more information, or to evaluate the DIEGO ELITE Multidebrider, please contact your Olympus representative or call 800-773-4301. To learn more about the product visit: <a href="http://www.medical.olympusamerica.com/diegoelite">www.medical.olympusamerica.com/diegoelite</a></p>
<p><strong>About Olympus Medical Systems Group </strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="http://www.medical.olympusamerica.com">www.medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong></p>
<p>Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<div>
<hr align="left" size="1" width="33%" /><div id="ftn1">
<p><a href="#_ftnref1" name="_ftn1" title="" id="_ftn1">[1]</a> Sindwani, R, Kumar, N. Bipolar microdebrider may reduce intraoperative blood loss and operating time during nasal polyp surgery. Ear Nose Throat Journal. 2012 Aug; 91(8):336-44.</p>
</div>
<div id="ftn2">
<p><a href="#_ftnref2" name="_ftn2" title="" id="_ftn2">[2]</a> Data on file.</p>
</div>
<div id="ftn5">
<p><a href="#_ftnref5" name="_ftn5" title="" id="_ftn5">[3]</a> Joniau, S. et al. Long-Term Comparison Between Submucosal Cauterization and Powered</p>
<p>Reduction of the Inferior Turbinate. Laryngoscope, 2006 Sept; 116:1612–1616.</p>
</div>
</div>
<p> </p>
</div></div></div>Wed, 25 Sep 2013 19:35:23 +0000joshua.boltz@olympus.com2460 at https://medical.olympuscanada.comOlympus’ Medical Business Launches New Website to Enhance Customer Experiencehttps://medical.olympuscanada.com/articles/olympus%E2%80%99-medical-business-launches-new-website-enhance-customer-experience
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Site offers cutting-edge features with new and improved<br />information on world-class medical technology</em></p>
<p>CENTER VALLEY, Pa., September 12, 2013 – Olympus, a precision technology leader in designing and delivering innovative medical and surgical solutions among other core businesses, announced today the launch of a cutting-edge website for its medical business. The new site, located at <a href="http://www.medical.olympusamerica.com/?utm_source=Olympus&amp;utm_medium=PR&amp;utm_campaign=MSG_Site_Launch&amp;utm_content=Body1">medical.olympusamerica.com</a>, is designed to improve the experience of customers and other stakeholders when engaging with the company online, making it easier to find products, services and a range of solutions that will ultimately benefit patients and help achieve the goals of the Affordable Care Act.</p>
<p>“As we embrace healthcare reform, Olympus is committed to working with healthcare providers to meet the changing needs of the marketplace,” said Luke Calcraft, President of the Medical Systems Group of Olympus Corporation of the Americas. “We are proud to offer our customers a website that is both easy to use and consistent with the advanced technology we deliver in our products, providing valuable information that will lead to high-quality patient care at an affordable cost.”</p>
<p>The new website is organized by specialty -- including gastroenterology, pulmonary, general surgery, urology and more -- with featured products and a range of customer resources. It also places an emphasis on the innovative technologies that enable physicians and surgeons to peer inside the human body to fight cancers and diagnose and treat a broad range of illnesses across a wide spectrum of specialties. Powered by Drupal, an open source web content management system, the new website provides flexibility in updating key product information and resources in today’s fast-paced healthcare environment, helping Olympus to technologically keep pace with the rapidly changing digital landscape.</p>
<p>Users can access <a href="http://www.medical.olympusamerica.com/?utm_source=Olympus&amp;utm_medium=PR&amp;utm_campaign=MSG_Site_Launch&amp;utm_content=Body2">medical.olympusamerica.com</a> on any internet-connected device with a browser. Healthcare professionals using a smart phone can access a mobile-optimized version to quickly connect with either the information or appropriate Olympus representatives they need, when they need it, while on the move within a healthcare facility.</p>
<p><strong>About Olympus Medical Systems Group</strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.medical.olympusamerica.com/?utm_source=Olympus&amp;utm_medium=PR&amp;utm_campaign=MSG_Site_Launch&amp;utm_content=Footer">medical.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Tue, 10 Sep 2013 21:08:36 +0000joshua.boltz@olympus.com2450 at https://medical.olympuscanada.comSenator Casey Visits New Olympus Medical Learning Centerhttps://medical.olympuscanada.com/articles/senator-casey-visits-new-olympus-medical-learning-center
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>New modern training facility provides backdrop for discussion on healthcare reform</em></p>
<p><strong>CENTER VALLEY, Pa., July 23, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative Medical and Surgical solutions, among other core businesses, announced today that U.S. Senator Bob Casey (D-PA) visited its new Medical Learning Center in the Lehigh Valley. Senator Casey met with the President of Olympus’ Medical Systems Group Luke Calcraft to tour the innovative facility and discuss issues affecting the medical device industry in the context of healthcare reform.</p>
<p>“I welcome the opportunity to discuss healthcare reform with stakeholders in Pennsylvania like Olympus,” said Senator Casey. “I look forward to working together to invest in medical technology that plays an important role in diagnosing and curing numerous diseases.”</p>
<p>Calcraft added, “We applaud the passion and commitment Senator Casey shows for healthcare reform and appreciate his understanding and support of the contribution our industry brings to the quality of life of millions of Americans, not to mention the positive impact of our business on employment opportunities in Eastern Pennsylvania. The new Medical Learning Center will help enhance the knowledge and expertise required to successfully use our world-class products and make a measurable impact on patients and physicians worldwide. We remain fully committed to meeting the needs of healthcare providers by providing cutting-edge medical products—most of which are aimed at early, minimally invasive diagnosis and treatment of diseases—that improve the quality of care, enhance patient satisfaction and reduce the total cost of healthcare.”</p>
<p>The Medical Learning Center, a 2,875 square foot modern training facility featuring new and innovative medical technology, will be used to train Olympus employees and distributor partners from across North and South America. The new facility supports Olympus’ commitment to excellence through comprehensive training of sales, marketing, field and technical support personnel on the safe and effective use of the company’s innovative medical and surgical products that, in the hands of healthcare professionals, help people lead more fulfilling lives.</p>
<p>Through Olympus’ partnership with Communities in Schools, the Company will also use the new facility to provide education programs related to its current Science, Technology, Engineering and Mathematics (STEM) initiatives as well as general career training to empower students with the educational resources to make a positive impact in their lives and future careers.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Thu, 22 Aug 2013 19:05:05 +0000joshua.boltz@olympus.com2412 at https://medical.olympuscanada.comOlympus Unveils New Medical Learning Center for the Americashttps://medical.olympuscanada.com/articles/olympus-unveils-new-medical-learning-center-americas
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="center"><em>Center Valley, PA facility to serve as central training hub for cutting-edge medical products across North and South America business operations</em></p>
<p><strong>CENTER VALLEY, Pa., July 2, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative Medical and Surgical solutions, among other core businesses, announced today that it will unveil its new Medical Learning Center in the Lehigh Valley.</p>
<p>The Medical Learning Center, a 2,875 square foot modern training facility featuring cutting-edge medical technology, will be used to train Olympus employees and distributor partners from across North and South America. The new facility supports Olympus’ commitment to excellence through comprehensive training of sales, marketing, field and technical support personnel on the safe and effective use of the company’s innovative medical and surgical products that, in the hands of healthcare professionals, help people lead more fulfilling lives.</p>
<p>"Training is a critical part of our business—it ensures that our employees, partners and subsequently, our customers, have a deep knowledge of our portfolio and understand how to harness the technical capabilities of our products to deliver cutting-edge, minimally invasive care in a safe and effective way," said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. "This enables us to address the requirements of healthcare reform through our portfolio of innovative technologies, most of which are aimed at early, minimally invasive diagnosis and treatment of diseases with obvious patient outcome and cost benefits."</p>
<p>The construction of the Medical Learning Center provides a significant financial investment in the local community by using Lehigh Valley commercial partners, including Diefenderfer Electrical, Multi-Tech Construction, Signs By Tomorrow-Allentown and Vistacom. The new facility will help bolster perceptions of the Lehigh Valley as a supportive, sophisticated environment for high-tech, innovative businesses.</p>
<p>In addition, through Olympus’ partnership with Communities in Schools, the Company will use the new facility to provide education programs related to its current Science, Technology, Engineering and Mathematics (STEM) initiatives as well as general career training to empower students with the educational resources to make a positive impact in their lives and future careers.</p>
<p>The Medical Learning Center will be unveiled this evening from 6:00 to 8:30pm EST with a private ribbon cutting ceremony including employees, partners, State Senator Pat Browne, and representatives of elected officials including Carol Obando-Derstine (Regional Manager for U.S. Senator Bob Casey), Marta Gabriel (Regional Manager for U.S. Senator Pat Toomey), and Lisa Walter (Chief of Staff for State Senator Bob Mensch).</p>
<p><strong>About Olympus Medical Systems Group</strong></p>
<p>Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information, visit Olympus at <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Mon, 01 Jul 2013 19:22:17 +0000joshua.boltz@olympus.com2332 at https://medical.olympuscanada.comOlympus Showcases ENDOEYE FLEX 5 at Premier's National Healthcare Innovation Eventhttps://medical.olympuscanada.com/articles/olympus-showcases-endoeye-flex-5-premiers-national-healthcare-innovation-event
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><strong>CENTER VALLEY, Pa., June 13, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative Medical and Surgical solutions among other core businesses, announced today that its <strong>ENDOEYE FLEX 5</strong> was one of 14 medical innovations on display in front of thousands of healthcare providers and experts at the Premier healthcare alliance’s 2013 Breakthroughs Conference and Exhibition.</p>
<p>Olympus’ ENDOEYE FLEX, the world’s first autoclavable 5mm HD deflectable videolaparoscope, was selected by clinicians and other members of Premier, a provider-owned performance improvement alliance of more than 2,800 hospitals and nearly 95,000 other care sites. Selection criteria included the uniqueness of the product, its ability to have an impact on an unmet medical need and its potential to positively impact patient care. The ENDOEYE FLEX 5 was showcased during the conference’s fifth annual <a href="https://www.premierinc.com/about/events-education/breakthroughs/2013/networking/index.jsp#innovation-celebration" target="_blank">Innovation Celebration</a> that recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.</p>
<p>“The ENDOEYE FLEX 5 represents a significant breakthrough in laparoscopic imaging and strengthens our portfolio of surgical products by enhancing the performance and functionality for surgeons for minimally invasive procedures,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “We remain fully committed to meeting the needs of healthcare providers by providing cutting-edge products that improve the quality of care, enhance patient satisfaction and reduce the total cost of healthcare.”</p>
<p>The ENDOEYE FLEX 5 offers HD resolution in a 5mm diameter scope providing bright, crisp images enabling surgeons to see fine details during surgery. The product allows 100 degree angulation in all directions providing complete visualization of complex anatomical structures.</p>
<p>In addition, the ENDOEYE FLEX 5 offers significant advantages for the surgeons and OR staff throughout the procedure. The product offers surgeons the flexibility to change the direction of view enabling them to visualize organs and tissue head-on, from above and from behind. The integrated all-in-one design enables easy setup and a simple plug-and-play operation. The advanced optical design makes the scope Focus Free eliminating manual focusing by the surgeon during the procedure. Following the procedure, the ENDOEYE FLEX 5 can be autoclaved simplifying the workflow and generating reprocessing cost savings for the hospital.</p>
<p><strong>About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award Recipient</strong><br />Premier is the nation’s largest performance improvement alliance of more than 2,800 U.S. hospitals and 95,000 other sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by healthcare providers, Premier operates a leading purchasing network with more than $5 billion in annual savings. Premier also maintains clinical, financial and outcomes databases based on 1 in every 4 patient discharges. A world leader in measurably improving patient care, Premier has the largest performance improvement collaboratives in America, including one in partnership with the Centers for Medicare &amp; Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. <a href="https://www.premierinc.com">https://www.premierinc.com</a>. Stay connected with Premier on Facebook, Twitter, LinkedIn and YouTube.</p>
<p><strong>About Olympus Medical Systems Group </strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.olympusamerica.com.">www.olympusamerica.com.</a></p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Mon, 01 Jul 2013 19:20:06 +0000joshua.boltz@olympus.com2331 at https://medical.olympuscanada.comOlympus Receives Contract with Premier Healthcare Alliance for THUNDERBEAT Advanced Energy Platformhttps://medical.olympuscanada.com/articles/olympus-receives-contract-premier-healthcare-alliance-thunderbeat-advanced-energy-platform
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>THUNDERBEAT Recognized as Breakthrough Innovative Technology </em><em>by Leading Group Purchasing Organization</em></p>
<p><strong>CENTER VALLEY, Pa., June 12, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative Medical and Surgical solutions, among other core businesses, announced today that its THUNDERBEAT Advanced Energy Platform has been added to the Surgical Energy agreement with Premier. This award is a result of a “Breakthrough Technology” process where THUNDERBEAT demonstrated significant differentiation to be added to the agreement mid-stream. The agreement offers specially negotiated pricing to Premier’s alliance of more than 2,800 hospitals and 95,000 providers nationwide.</p>
<p>THUNDERBEAT is the world’s only platform that combines advanced bipolar and ultrasonic energies into a single multi-functional hand instrument allowing surgeons to simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread. Additionally, it boasts the fastest cutting speed, delivers reliable vessel sealing, and provides the highest grasping forces at the tip when compared to the leading energy instruments currently on the market.</p>
<p>"We are very excited to be selected by Premier as a preferred vendor for our THUNDERBEAT Advanced Energy Platform,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “THUNDERBEAT eliminates the need for surgeons to choose between the benefits of bipolar or ultrasonic energy by combining both energies into a single, universal system. This helps hospitals meet the demands of today’s healthcare environment by realizing cost savings while providing quality care.”</p>
<p>THUNDERBEAT, when combined with the versatility of the ESG-400 electrosurgical generator, is the only platform that delivers every common form of energy used in surgery today (monopolar, bipolar, ultrasonic and advanced bipolar) as well as the revolutionary combination of advanced bipolar and ultrasonic energies. </p>
<p>THUNDERBEAT was recognized by Premier as a Breakthrough Innovation Technology and was one of 14 medical innovations on display in front of thousands of healthcare providers and experts at the Premier healthcare alliance’s <a href="https://www.premierinc.com/breakthroughs/" target="_blank">2013 Breakthroughs Conference and Exhibition</a>. In addition, the technology was showcased during the conference’s fifth annual Innovation Celebration that took place on June 11 in San Antonio. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.</p>
<p><strong>About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award Recipient</strong><br />Premier is the nation’s largest performance improvement alliance of more than 2,800 U.S. hospitals and 95,000 other sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by healthcare providers, Premier operates a leading purchasing network with more than $5 billion in annual savings. Premier also maintains clinical, financial and outcomes databases based on 1 in every 4 patient discharges. A world leader in measurably improving patient care, Premier has the largest performance improvement collaboratives in America, including one in partnership with the Centers for Medicare &amp; Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. <a href="https://www.premierinc.com">https://www.premierinc.com</a>. Stay connected with Premier on Facebook, Twitter, LinkedIn and YouTube.</p>
<p><strong>About Olympus Medical Systems Group </strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.olympusamerica.com">www.olympusamerica.com. </a></p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Mon, 17 Jun 2013 17:59:33 +0000joshua.boltz@olympus.com2330 at https://medical.olympuscanada.comOlympus Endoscopes Now Powered by Next-Generation Ultrasound Processorhttps://medical.olympuscanada.com/articles/olympus-endoscopes-now-powered-next-generation-ultrasound-processor
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p align="left"><em>ProSound F75 Ultrasound Imaging Platform enables More Accurate Diagnosis of Cancers in GI Tract </em></p>
<div style="float: right; width: 200px; margin-left: 20px;"><img align="right" alt="Prosound 75" src="http://www.olympusamerica.com/msg_section/images/prosound75.jpg" /></div>
<p><strong>CENTER VALLEY, Pa., May 14, 2013 - </strong>Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that the Company’s ultrasound endoscopes will now be powered by the ProSound F75 Ultrasound Processor.</p>
<p>The ProSound F75 Ultrasound Processor, developed in partnership by Hitachi Aloka Medical, Ltd., provides physicians with the highest quality imaging—that aids in more accurate diagnosis of diseases of the GI track and surrounding organs such as the pancreas, bile duct, liver, spleen and gallbladder as well as assessing a variety of cancers. The newly introduced platform improves workflow from pre-examination to after examination for better data management, and provides improved visualization for more accurate blood flow information.</p>
<p>“The ProSound F75 delivers outstanding image quality that facilitates easy identification and more accurate staging of GI tumors in my practice,” said Dr. Shyam Varadarajulu, Medical Director of the Center for Interventional Endoscopy (CIE) and Professor of Medicine at the University of Central Florida. “The images are crisp with excellent resolution and the technology is truly versatile in its functionality.”</p>
<p>The ProSound F75 Ultrasound Processor offers a unique ergonomic capability with an adjustable height and depth of the keyboard and monitor that provides comfort to all endoscopists in a practice. The ProSound F75 has versatile capabilities for conducting quick tasks and examinations in every clinical setting. In addition, the device is forward and backward compatible which allows it to work with most endoscopic ultrasound (EUS) and endobronchial ultrasound (EBUS) scopes.</p>
<p>“We are very pleased to partner with Hitachi Aloka Medical, Ltd. and provide our customers with a complete solution for imaging that addresses both their clinical and operational needs,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “The ProSound F75 enables physicians to realize clinical efficacy through premier imaging and helps healthcare facilities to achieve efficient asset management through forward and backward scope compatibility of the platform.”</p>
<p>Olympus is a pioneer of <a href="http://www.olympusamerica.com/presspass/press_pass_cut/documents/EUSBackgrounder_711.pdf" target="_blank">endoscopic ultrasound</a> (EUS) which combines ultrasound technology with endoscopy to better visualize the tissues of the digestive tract and adjacent anatomical structures inside the human body. Conventional ultrasound is performed by placing a transducer against the skin to produce images of internal organs. With EUS, the transducer is endoscopically inserted into the body via the digestive tract, putting it closer to the area of interest to obtain higher resolution images. </p>
<p>This technology addresses the key requirements of Healthcare Reform:</p>
<ul><li><strong>Increased Quality of Care</strong> – EUS drives optimal patient outcomes through easy identification and more accurate staging of diseases and cancers in the GI tract.</li>
<li><strong>Decreased Costs</strong> – The forward and backward compatibility provides significant cost savings through lower cost of ownership and more efficient use of assets.</li>
<li><strong>Enhanced Patient Satisfaction</strong> – EUS provides a less invasive approach than conventional surgical diagnosis allowing physicians to view internal anatomy without making an incision.</li>
</ul><p>According to the American Cancer Society, there are more than 125,000 newly diagnosed cases of gastrointestinal cancer each year in the United States with more than 91,000 deaths from these diseases in 2013. In addition, Truven Health estimates that the total number of EUS outpatient procedures will grow 15% from 2011 to 2016 and reach 235,000 procedures.<br /> <br />The ProSound F75 Ultrasound Processor will be showcased at the Digestive Disease Week (DDW) 2013 Annual Meeting to be held May 18-21 in Orlando, FL. Physicians are invited to visit booth #548 to further explore the benefits of the new ultrasound imaging platform.</p>
<p>For more information or to evaluate the ProSound F75 Ultrasound Processor, please contact your Olympus representative or call 800-848-9024.</p>
<p><strong>About Olympus Medical Systems Group</strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
<p><strong>About Hitachi Aloka </strong><strong>Medical, Ltd. (Subsidiary of Hitachi Medical Corporation)</strong><br />Hitachi Aloka Medical, Ltd. is committed to delivering advanced diagnostic ultrasound systems to meet the needs of physicians and patients. The company was formed when Aloka Co., Ltd. became a 100% subsidiary of Hitachi Medical Corporation on March 3, 2011 and changed its name to Hitachi Aloka Medical, Ltd. on April 1, 2011. Aloka commercialized medical ultrasound equipment for the first time in the world in 1960 and as Hitachi Aloka Medical, Ltd. continues to promote the ultrasound business under its highly valued Aloka brand. With its U.S. headquarters in Wallingford, CT, Hitachi Aloka Medical America employs local sales, service and clinical applications professionals across the nation. <a href="http://www.hitachi-aloka.com" target="_blank">www.hitachi-aloka.com</a></p>
</div></div></div>Wed, 05 Jun 2013 19:20:08 +0000joshua.boltz@olympus.com2328 at https://medical.olympuscanada.comOlympus Introduces World’s Only Fully Rotatable HD Bronchoscopes https://medical.olympuscanada.com/articles/olympus-introduces-world%E2%80%99s-only-fully-rotatable-hd-bronchoscopes
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>BF-190 bronchoscopes provide physicians and surgeons with unparalleled maneuverability and flexibility intended to expand reach within the endobronchial tree</em></p>
<p><strong>CENTER VALLEY, Pa., May 2, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative Medical and Surgical solutions, among other core businesses, announced today the commercial availability of its 510(k) cleared BF-190 bronchoscopes.</p>
<p>The new BF-190 bronchoscopes offer unparalleled maneuverability and flexibility through the combination of their unique Rotary Function and wider tip angulation*, which will potentially allow physicians to access areas of the lung that may not be easily reached with current generation bronchoscopes. The Rotary Function is estimated to reduce hand torque by up to 82%** which may translate to a significant reduction in hand fatigue and injury.</p>
<p>“Increased maneuverability is perceived to be the most notable improvement in functionality compared to existing bronchoscopes,” said Dr. Ali Musani, Director of Interventional Pulmonology at the National Jewish Hospital. “Translating this feature to bronchoscopes will allow for easier access to traditionally difficult-to-reach locations and in some cases may permit navigation into areas impossible to reach with current generation bronchoscopes.”</p>
<p>The BF-190 bronchoscopes are powered by Olympus’ new EVIS EXERA III Universal Platform, the only HDTV Imaging system that helps facilitate more accurate bronchoscopic diagnosis and treatment, simplify setup and reprocessing, and improve versatility. The HDTV image, along with other enhanced features from the EVIS EXERA III processor and light source, will provide a clear and detailed endoscopic image that allows for more precise observation.</p>
<p>The EVIS EXERA III system works seamlessly with a wide range of endoscopes across specialties to provide easier data management and cost efficiencies. The system is compatible with all Olympus endoscopes used in bronchoscopy, endo-bronchial ultrasound (EBUS), gastroenterology, laparoscopic and arthroscopic surgery, urology, anesthesiology and ENT. The flexibility of this widespread platform helps facilities reduce their need for multiple video systems, thereby improving asset management by meeting the needs for endoscopic observation and minimally invasive surgery throughout the hospital.</p>
<p>“The BF-190s represent one of the most significant advancements in bronchoscopes in over eight years,” said Luke Calcraft, President of the Medical Systems Group at Olympus America Inc. “We believe that the technology provides unique functionality which, when combined with the brightest, clearest image on the market, has the potential to transform the way bronchoscopies are performed throughout the world.”</p>
<p>Olympus is a pioneer in developing innovative solutions to advance the field of <a href="http://www.olympusamerica.com/presspass/press_pass_cut/documents/BronchoscopyBackgrounder.pdf" target="_blank">bronchoscopy</a>. According to Thomson Reuters, there were approximately 850,000 bronchoscopies performed in the U.S. in 2010. In addition, more than 220,000 people are diagnosed with lung cancer each year according to the Centers for Disease Control and Prevention (CDC). Lung cancer takes more lives than breast, prostate and colon cancers combined, accounting for 27% of all cancer deaths.</p>
<p>The BF-190 bronchoscopes will be showcased at the American Association for Thoracic Surgery (AATS) Annual Meeting to be held May 4-8 in Minneapolis (booth #1730) and the American Thoracic Society (ATS) International Conference to be held May 17-22 in Philadelphia (booth #210). Physicians and Surgeons are invited to further explore the benefits of the BF-190 bronchoscopes.</p>
<p>For more information or to order the BF-190 bronchoscopes, please contact your Olympus representative or call 800-548-5515.</p>
<p><em>*Available in BF-Q190 and BF-H190 models</em></p>
<p><em>**When compared to Olympus bronchoscopes (data on file)</em></p>
<p><strong>About Olympus Medical Systems Group</strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.olympusamerica.com." target="_blank">www.olympusamerica.com. </a></p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Wed, 05 Jun 2013 19:19:20 +0000joshua.boltz@olympus.com2327 at https://medical.olympuscanada.comOlympus Introduces the World's Only Articulating HD 3D Laparoscopic Surgical Video Systemhttps://medical.olympuscanada.com/articles/olympus-introduces-worlds-only-articulating-hd-3d-laparoscopic-surgical-video-system
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p style="text-align:center;"><em>Technology Improves Speed, Accuracy and Precision of Surgical Procedures<br />When Compared with 2D Surgical Systems</em></p>
<p><strong>CENTER VALLEY, Pa., April 9, 2013</strong> – Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Articulating HD 3D Laparoscopic Surgical Video System.</p>
<p>The Olympus Articulating HD 3D Laparoscopic Surgical Video System delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon's skill level.</p>
<p>The Olympus HD 3D system is ideal for suturing, accurately identifying tissue planes and other precision surgical tasks that are required in my laparoscopic surgical cases, said Dr. Marcos Michellotti, Assistant Professor of Surgery at Loma Linda University Health System in Loma Linda, California. In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3D without losing the important visual horizon. This is not possible with traditional fixed angle laparoscopes.</p>
<p>Another significant advantage of the new Olympus HD 3D video platform is its availability as a module that can be easily added to an existing Olympus EVIS EXERA III Universal Imaging System. The modular design reduces the investment necessary to add 3D capability, and allows the surgeon to choose either 2D or 3D visualization from the surgical field. This helps to reduce capital investments and simplify asset management and training.</p>
<p>"The Olympus HD 3D System brings value to those surgeons that need the precision, resolution, and depth perception of 3D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology," said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. "We are leading the way with innovations to help our customers realize the clinical efficacy and cost effectiveness required under Accountable Care."</p>
<p>Olympus is a pioneer of minimally invasive surgery (<a href="/sites/default/files/pdf/LaparoscopyBackgrounder.doc">Laparoscopy</a>), a modern technique in which an operation in the abdomen is performed through small incisions as compared to larger incisions needed in traditional surgical procedures. This surgical approach addresses the key requirements of Healthcare Reform:</p>
<ul><li><strong>Increased Quality of Care</strong> – Minimally invasive surgery provides better clinical outcomes than traditional "open" surgery.</li>
<li><strong>Decreased Costs</strong> – Numerous industry and clinical studies have demonstrated that minimally invasive surgery provides significant cost savings when compared to a robotic surgical approach.*</li>
<li><strong>Enhanced Patient Satisfaction</strong> – Minimally invasive surgery provides less scarring, shorter hospital stays and faster recovery than traditional "open" surgery.</li>
</ul><p>The Olympus Articulating HD 3D Laparoscopic Surgical Video System will be showcased at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2013 Annual Meeting to be held April 17-20 in Baltimore, MD. Surgeons are invited to visit booth #111 and experience the benefits of the HD 3D technology.</p>
<p>For more information or to evaluate the HD 3D Laparoscopic Surgical Video System, please contact your Olympus representative or call 800-548-5515.<br /><em>*Data on file.</em></p>
<p><strong>About Olympus Medical Systems Group</strong><br />Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information visit Olympus at <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Michael Levey, Olympus, 484-896-5120, <a href="mailto:michael.levey@olympus.com">michael.levey@olympus.com</a></p>
</div></div></div>Mon, 15 Apr 2013 18:13:47 +0000joshua.boltz@olympus.com2323 at https://medical.olympuscanada.comOlympus' Revolutionary System Allows Advanced Surgery Through Dime-Size Incisionhttps://medical.olympuscanada.com/articles/olympus-revolutionary-system-allows-advanced-surgery-through-dime-size-incision
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>Olympus develops cutting-edge technological system better enabling Laparoendoscopic Single Site Surgery.</em></p>
<p><strong>Center Valley, PA and Southborough, MA, October 1, 2012</strong> - Olympus announces the availability of a revolutionary surgical system allowing surgeons to remove the gallbladder through the belly button using a single incision of only 12-15mm in size – a solution only Olympus is offering at this time. This one-of-a-kind system, developed over a five year period, will better enable Laparoendoscopic Single Site Surgery (LESS) and encourage a wider spread adoption of using a single incision for gallbladder removal.</p>
<p>Working closely with leading surgeons and Advanced Surgical Concepts (ASC), Olympus developed the components necessary to conduct LESS procedures such as LESS Cholecystectomy (the surgical removal of the gallbladder), including an access port device (manufactured by ASC), instrumentation, and a state-of-the-art, high-definition, flexible tip laparoscope with imaging capabilities. These components have been designed to work seamlessly together and their integration is critical to the success of performing single-site surgery.</p>
<p>Gallbladder surgery is one of the most common surgical procedures performed in the United States with nearly one million conducted every year. Up until now, the surgery has been performed through four small incisions - each of which can cause scarring, pain, bleeding, infection and hernia. Olympus’ new system now makes it possible for surgeons to perform the procedure through one dime-size incision using four instruments rather than creating four separate incisions.</p>
<p>“Olympus was one of the first companies to pioneer the development of the LESS market,” commented Richard Reynolds, Executive Vice President, Olympus America Inc. “We recognized early on that to be successful, we had to work closely with the surgical community and produce a solution that would allow surgeons to safely and effectively use this new approach.”</p>
<p>Single-site surgery is still in its infancy in the United States; however, a group of internationally recognized surgeons from the United States, Europe and Asia recently published a white paper in the journal, Surgical Endoscopy, describing a standardized methodology for LESS Cholecystectomy. This standardization aims to smooth the transition to LESS procedures for the surgical community.</p>
<p>“I have tried single-site surgery in my practice and found it achievable,” stated Dr. Henry Davison Jr., Princeton Surgical Associates, P.A., Plainsboro, New Jersey. “I have started to use the standardized method and have found the procedure and my time commitment to be as manageable as my previous four-port technique. My practice has been building by word of mouth as a result of the LESS option, and most importantly, my patients are pleased with the results and minimization of scars. Also, the length of stay seems to be much shorter, with patients going home from the recovery room soon after surgery.”</p>
<p>Olympus views the advent of LESS as a profound advancement in the potential for patient care. Olympus will continue to dedicate itself to the development of surgical solutions across a range of procedures as well as new technologies and methodologies that will enable the surgical community to offer patients the highest quality of care through minimally invasive procedures.</p>
<p>To learn more about LESS procedures, visit <a href="http://www.olympusamerica.com/LESS" target="_blank">www.olympusamerica.com/LESS</a>.</p>
<p><strong>About Olympus Medical Systems</strong><br />Olympus develops solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare. For more information about Olympus America, visit <a href="http://www.olympusamerica.com" target="_blank">www.olympusamerica.com</a>.</p>
<p><strong>About Advanced Surgical Concepts</strong><br />Advanced Surgical Concepts (ASC) was established in July 1998 to increase the number of Abdominal Surgeries performed endoscopically through the development of new access technologies. ASC has developed a series of revolutionary access systems that will enable surgeons to utilize endoscopic approaches for abdominal surgery. For more information, visit <a href="http://www.advancedsurgical.ie" target="_blank">www.advancedsurgical.ie</a>.</p>
<p><strong>Olympus Media Contact</strong><br />Mark Miller, Olympus, 484-896-3020, <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a></p>
<p><strong>ASC Media Contact</strong><br />Olwen Coughlan, ASC, +353 1 2864777, <a href="mailto:ollie@advancedsurgical.ie">ollie@advancedsurgical.ie</a></p>
</div></div></div>Wed, 17 Oct 2012 18:36:48 +0000rnunamaker1508 at https://medical.olympuscanada.comOlympus Introduces the World's First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)https://medical.olympuscanada.com/articles/olympus-introduces-worlds-first-and-only-monopolar-disposable-tonsil-adenoid-debrider-dtad
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>The Olympus DTAD includes 3 industry firsts in one device combining monopolar energy, a battery-powered debrider, and a malleable shaver blade that can be set at 40° for adenoids, 15° for tonsils, or anywhere in between.</em></p>
<p><strong>Center Valley, PA and Southborough, MA, September 11, 2012</strong> — Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced their FDA-cleared DTAD (Disposable Tonsil Adenoid Debrider) at this year's AAO-HNSF annual meeting.</p>
<p>The Olympus DTAD is the world's first and only disposable tonsil adenoid debrider that combines monopolar energy and distal suction with a malleable shaver blade. Using proprietary FLEXBLADE Technology, DTAD's malleable shaver blade is designed to provide optimum access to adenoid and tonsil anatomy in a singular device without requiring the exchange of blade parts or use of tools during a procedure. DTAD is also the world's only battery-powered debrider, making it easy to set up and easy to use without any additional capital investment in a console or other equipment.</p>
<p>“By combining monopolar energy with a malleable shaver blade, Olympus' unique DTAD allows the surgeon to cut and coagulate with a single device, reducing the need to exchange instruments,” says Sandra Tilden, Vice President of Marketing for Olympus’ Surgical Business. “DTAD also plugs into any standard monopolar generator so our customers can realize capital efficiencies by not having to purchase a new console.”</p>
<p>As a battery-powered device that also does not require irrigation or a dedicated console, DTAD makes faster setup time possible through “Plug and Play” implementation. In addition, distal suction allows the shaver blade to be used as a suction device for blood and fluid leading to better visualization of the surgical site.</p>
<p>“Our mission is to design, develop, and manufacture world-class, innovative solutions like DTAD as we strive to help make surgery safer, easier and more efficient for our customers,” says Georg Schloer, President of Olympus Surgical Technologies America which is a manufacturing arm of Olympus. “Olympus is committed to helping surgeons and physicians perform advanced procedures to elevate the standards of patient care and deliver better treatment, while improving outcomes and enhancing the quality of life.”</p>
<p>The Olympus DTAD is scheduled to be available in the U.S in the fourth quarter of 2012.</p>
<p>Image 1 text: The Olympus DTAD, the world’s first and only monopolar, disposable tonsil adenoid debrider, shown with close-up of shaver blade and illustration of 15 to 40 degree range of motion with Olympus’ proprietary FLEXBLADE technology.</p>
<p>Image 2 text: The Olympus DTAD, the world’s first and only monopolar, disposable tonsil adenoid debrider, shown with plug designed for any standard monopolar generator.</p>
<p><strong>About Olympus</strong><br />Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products.</p>
<p>Olympus works collaboratively with its customers and affiliates worldwide to leverage R&amp;D investment in precision technology and manufacturing processes across diverse business lines. These include:</p>
<ul><li>Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;</li>
<li>Advanced research, clinical and educational microscopes and research and educational digital imaging systems;</li>
<li>Industrial research, engineering, test, inspection and measuring instruments; and</li>
<li>Digital cameras and voice recorders.</li>
</ul><p>Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contacts:</strong><br />Mark Miller, Olympus America Inc., (484) 896-3020, <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a></p>
</div></div></div>Wed, 17 Oct 2012 18:31:37 +0000rnunamaker1507 at https://medical.olympuscanada.comOlympus THUNDERBEAT Recognized as a 2012 Innovation of the Yearhttps://medical.olympuscanada.com/articles/olympus-thunderbeat-recognized-2012-innovation-year
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>The Society of Laparoendoscopic Surgeons selects world’s only fully-integrated advanced bipolar and ultrasonic energy platform as one of four award recipients.</em></p>
<p><strong>Center Valley, PA., September 10, 2012 </strong>- The Society of Laparoendoscopic Surgeons (SLS), the largest minimally invasive and laparoscopic society in North America, recently selected Olympus' THUNDERBEAT as one of their ‘2012 Innovations of the Year.’ In selecting recipients, SLS recognizes the most innovative products of the year that have a multidisciplinary application in minimally invasive surgery.</p>
<p>THUNDERBEAT is the world's only surgical device that combines advanced bipolar and ultrasonic energies into a single multi-functional hand instrument, allowing surgeons to simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread. When combined with the versatility of the ESG-400 electrosurgical generator, THUNDERBEAT is the only surgical tissue management system that delivers every common form of energy used in surgery today (monopolar, bipolar, ultrasonic, and advanced bipolar) as well as the revolutionary combination of advanced bipolar and ultrasonic energies.</p>
<p>“It is an honor to have THUNDERBEAT distinguished by SLS as one of their 2012 Innovations of the Year,” commented Sandra Tilden, Vice President of Marketing, Surgical Business, Olympus America Inc. “This award symbolizes Olympus’ commitment and aim to advance medical and surgical techniques through technological solutions and innovative products such as THUNDERBEAT.”</p>
<p>Olympus’ THUNDERBEAT was one of only four products acknowledged by SLS as a 2012 Innovation of the Year. Allison Toth, Product Manager for Olympus, accepted the award on Wednesday, September 5th at Minimally Invasive Surgery Week - SLS • MIRA • SRS Joint Annual Meeting and Endo Expo 2012 in Boston, MA.</p>
<p>Olympus also earned SLS’ Innovation of the Year award in 2007 for the UCR CO2 intra-luminal insufflation unit and in 2010 for the HALO PKS Cutting Forceps.</p>
<p><strong>About SLS</strong><br />The Society of Laparoendoscopic Surgeons was established as an educational, non-profit organization to help ensure the highest standards for the practice of laparoscopic, endoscopic and minimally invasive surgery. The Society serves surgeons from various specialties and other health professionals who are interested in advancing their expertise in the diagnostic and therapeutic uses of Laparoendoscopic and minimally invasive surgical techniques. With an international membership of over 6,000 surgeons, the organization offers a unique approach to the study and education of minimally invasive surgery by bringing together different medical specialties that use the techniques and tools of minimally invasive surgery.</p>
<p><strong>About Olympus </strong><br />Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products.</p>
<p>Olympus works collaboratively with its customers and affiliates worldwide to leverage R&amp;D investment in precision technology and manufacturing processes across diverse business lines. These include:</p>
<ul><li>Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;</li>
<li>Advanced research, clinical and educational microscopes and research and educational digital imaging systems;</li>
<li>Industrial research, engineering, test, inspection and measuring instruments; and</li>
<li>Digital cameras and voice recorders.</li>
</ul><p>Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit <a href="http://www.olympusamerica.com" target="_blank">www.olympusamerica.com</a>.</p>
<p><strong>Media Contacts:</strong><br />Mark Miller, Olympus America Inc., (484) 896-3020, <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a></p>
</div></div></div>Wed, 17 Oct 2012 18:26:09 +0000rnunamaker1506 at https://medical.olympuscanada.comGyrus ACMI Honored By Premier Healthcare Alliance for Operational Excellencehttps://medical.olympuscanada.com/articles/gyrus-acmi-honored-premier-healthcare-alliance-operational-excellence
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><strong>Center Valley, PA., August 16, 2012</strong> - Premier Inc., a leading healthcare purchasing network, recently honored Gyrus ACMI, an Olympus Company, as a performance Award partner for operational excellence.</p>
<p>In its announcement, Premier applauded the efforts of Gyrus whose performance exceeded operational expectations. Winners are recognized for their outstanding management of Premier agreements and dedication toward the mutual goal of providing clinical and financial value to Premier alliance members. In selecting recipients, performance data is collected and scored over four successive calendar quarters. Only 41 out of 800 suppliers received the Performance Award in 2012.</p>
<p>Mike McNaughton, Vice President of Olympus’ Corporate Accounts, accepted the award on June 7 at Premier's 2012 Annual Breakthroughs Conference and Exhibition in Nashville, Tenn. “We are honored to be recognized as a 2012 Premier Performance Award winner,” commented Mike McNaughton. “We understand the importance of our role as a business partner and trusted provider; this award symbolizes our commitment to our partnership with Premier.”</p>
<p>“It was again an honor for the team to be recognized for the additional value and support we provide to Premier and its members,” stated Florence Hayes, Director of Contract Administration. “It confirms my belief that we are using best practices to fulfill the requirements of our agreements.”</p>
<p>“As providers continue efforts to operate in a high quality, cost-effective environment, Gyrus ACMI has truly been supporting Premier alliance members,” said Mike Alkire, Premier COO. “We're proud to recognize them as a top performing organization.”</p>
<p>Olympus and Gyrus ACMI have collectively received awards from Premier for the last six consecutive years, demonstrating and proving our commitment to excellence in managing the Premier Agreements and bringing value to its members.</p>
<p><strong>About the Premier healthcare alliance, Malcolm Baldrige National Quality Award recipient</strong><br />Premier is a performance improvement alliance of more than 2,600 U.S. hospitals and 84,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare &amp; Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. For more information about Premier, visit <a href="http://www.premierinc.com">http://www.premierinc.com</a></p>
<p><strong>About Olympus Medical Systems</strong><br />Olympus develops solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.</p>
<p>For more information about Olympus America, visit <a href="http://www.olympusamerica.com">www.olympusamerica.com</a>.</p>
<p><strong>Media Contact</strong><br />Mark Miller, Olympus, (484) 896-3020, <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a></p>
</div></div></div>Wed, 17 Oct 2012 18:21:20 +0000rnunamaker1505 at https://medical.olympuscanada.comOlympus Introduces the World's Only Integrated Bipolar and Ultrasonic Energy Platformhttps://medical.olympuscanada.com/articles/olympus-introduces-worlds-only-integrated-bipolar-and-ultrasonic-energy-platform
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>Olympus' THUNDERBEAT surgical hand instrument delivers both Advanced Bipolar and Ultrasonic energy from a single multi-functional device.</em></p>
<p><strong>Center Valley, PA. (March 21, 2012)</strong> — Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced FDA clearance of its revolutionary Thunderbeat hand instruments and universal surgical platform.</p>
<p>Thunderbeat is the world's only surgical device that combines advanced bipolar and ultrasonic energies into a single multi-functional hand instrument allowing surgeons to simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread. Additionally, it boasts the fastest cutting speed, delivers reliable vessel sealing, and provides the highest grasping forces at the tip when compared to the leading energy instruments currently on the market.</p>
<p>"This is a significant advancement in surgical energy instrument technology," stated Charlie Goodwin, Group Vice President of Olympus' Surgical Business. "Previously, surgeons had to choose between the benefits of bipolar or ultrasonic energy when selecting an advanced energy instrument. Thunderbeat eliminates that difficult decision by combining both energies into a single multi-functional instrument," added Goodwin.</p>
<p>Thunderbeat, when combined with the versatility of the ESG-400 electrosurgical generator, is the only surgical tissue management system that delivers every common form of energy used in surgery today (monopolar, bipolar, ultrasonic and advanced bipolar) as well as the revolutionary combination of advanced bipolar and ultrasonic energies. This will appeal to hospital administrators interested in the cost savings associated with standardizing on a single energy platform as it could reduce the number of discrete systems required in any given surgical procedure. Additionally, Thunderbeat includes a standard 5-year warranty within the U.S. only.</p>
<p>"Our aim as a leading global healthcare company is to advance medical and surgical techniques and minimally invasive procedures, through the development of inspiring technological solutions and innovative products like Thunderbeat, that overcome the day-to-day constraints that physicians and surgeons face,” said Luke Calcraft, President of Olympus Corporation of the Americas’ Medical Systems Group. “Olympus is committed to helping physicians and surgeons perform advanced procedures that elevate the standards of patient care and deliver better treatment, while improving outcomes and enhancing quality of life,” continued Calcraft.</p>
<p><strong>About Thunderbeat</strong><br />Thunderbeat joins Olympus' extensive portfolio of surgical energy devices and hand instruments. It is the world's only platform that combines advanced bipolar and ultrasonic energies into a single, multi-functional hand instrument, allowing surgeons to rapidly and simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread.</p>
<p>Thunderbeat hand instruments can be used in Open, Laparoscopic (including Single-Site surgery) General Surgery, Urologic Surgery, Gynecologic Surgery, Thoracic Surgery, Plastic and Reconstructive Surgery, Bowel Resection, Cholecystectomy, Nissen Fundoplication, Adhesiolysis, Oophorectomy, Hysterectomy (both vaginally assisted and abdominal) and Endoscopic Surgery, or in any procedure in which cutting, vessel ligation (sealing and cutting), coagulation, grasping, and dissection is performed.</p>
<p>Thunderbeat has not been shown to be effective for tubal sterilization and should not be used for these procedures.</p>
<p>For more information about Olympus’ Thunderbeat products visit <a href="http://www.olympusamerica.com/thunderbeat" target="_blank">www.olympusamerica.com/thunderbeat</a> or <a href="/content/contact-olympus-america">contact</a> your sales representative.</p>
</div></div></div>Wed, 17 Oct 2012 18:16:02 +0000rnunamaker1504 at https://medical.olympuscanada.comOlympus Unveils New Dissolvable Post Sinus Surgery Productshttps://medical.olympuscanada.com/articles/olympus-unveils-new-dissolvable-post-sinus-surgery-products
<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><em>Exclusive Agreement grants Olympus’ ENT Group exclusive US product distribution</em></p>
<p><strong>Center Valley, PA, January 5, 2012</strong> — Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.</p>
<p>Through a distribution partnership with <a href="http://www.hemostasisllc.com">Hemostasis, LLC</a>, the plant-based and chitosan compositions have been formulated to improve post sinus surgery recovery, comfort and healing. All products are biocompatible, dissolve naturally, require no mixing or special storage considerations and are easily conformed to fit nasal anatomy. Additionally, the sinus products minimize edema, bleeding and prevent post operative adhesions by maintaining space between the upper chambers of the nasal cavities.</p>
<p>“The new offerings extend Olympus’ current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients,” commented Perry Mykleby, Vice President of Marketing for Olympus' ENT sales. “We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care.”</p>
<p>“Hemostasis is committed to providing the most comprehensive, technologically advanced ENT sinus spacing and hemostat technologies that are safe and effective for their intended use,” said Hemostasis’ President, Keith Roberts. “Working directly with leading physicians, we have developed practical technologies designed to optimize physician usability and efficacy, which ultimately have improved procedure outcomes and enhances overall patient care.”</p>
<p><strong>About Olympus Medical Systems ENT Business</strong><br />Olympus develops procedure solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. Our ENT Business offers advanced visualization and treatment products for Rhinology, Pediatric ENT, Laryngology, Otology, Sleep and Head and Neck procedures. Products include endoscopy and video; powered electrosurgical and manual instruments, middle ear prosthetics, and vent (PE) tubes.</p>
<p>For more information about Olympus America, visit <a href="http://www.olympusamerica.com" target="_blank">www.olympusamerica.com</a>.<br />For more information about ENT products, <a href="/specialty/ent">click here</a>.</p>
<p><strong>About Hemostasis, LLC</strong><br />Hemostasis is a dynamic company committed to developing and marketing innovative technologies for the rapidly changing demands of the global medical industry. We work directly with leading physicians to develop practical products that are designed to optimize usability and efficacy for medical professionals, improve procedure outcomes and enhance overall patient care. <a href="http://www.hemostasisllc.com">www.hemostasisllc.com</a>.</p>
<p><strong>Media Contacts:</strong><br />Mark Miller, Olympus, (484) 896-3020, <a href="mailto:mark.miller@olympus.com">mark.miller@olympus.com</a><br />Keith Roberts, Hemostasis, (651) 855-1466, <a href="mailto:kroberts@hemostasisllc.com">kroberts@hemostasisllc.com</a></p>
</div></div></div>Wed, 17 Oct 2012 18:06:38 +0000rnunamaker1503 at https://medical.olympuscanada.com